

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>SMARCB1/INI1-deficient tumors of adulthood | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/9-662/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/9-662" />
    
            <meta name="description" content="Read the original article in full on F1000Research: SMARCB1/INI1-deficient tumors of adulthood" />
    
            <meta name="og:title" content="F1000Research Article: SMARCB1/INI1-deficient tumors of adulthood.">
            <meta name="og:description" content="Read the latest article version by Nathaniel A. Parker, Ammar Al-Obaidi, Jeremy M. Deutsch, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="27370">
            <meta name="article-id" content="24808">
            <meta name="dc.title" content="SMARCB1/INI1-deficient tumors of adulthood">
            <meta name="dc.description" content="The SMARCB1/INI1 gene was first discovered in the mid-1990&rsquo;s, and since then it has been revealed that loss of function mutations in this gene result in aggressive rhabdoid tumors. Recently, the term &ldquo;rhabdoid tumor&rdquo; has become synonymous with decreased SMARCB1/INI1 expression. When genetic aberrations in the SMARCB1/INI1 gene occur, the result can cause reduced, complete loss, and mosaic expression. Although SMARCB1/INI1-deficient tumors are predominantly sarcomas, this is a diverse group of tumors with mixed phenotypes, which can often make the diagnosis challenging. Prognosis for these aggressive tumors is often poor. Moreover, refractory and relapsing progressive disease is common. As a result, accurate and timely diagnosis is imperative. Despite the SMARCB1/INI1 gene itself and its implications in tumorigenesis being discovered over two decades ago, there is a paucity of rhabdoid tumor cases reported in the literature that detail SMARCB1/INI1 expression. Much work remains if we hope to provide additional therapeutic strategies for patients with aggressive SMARCB1/INI1-deficient tumors.">
            <meta name="dc.subject" content="SMARCB1, INI1, loss of function mutation, rhabdoid, sarcoma">
            <meta name="dc.creator" content="Parker, Nathaniel A.">
            <meta name="dc.creator" content="Al-Obaidi, Ammar">
            <meta name="dc.creator" content="Deutsch, Jeremy M.">
            <meta name="dc.date" content="2020/06/30">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.24808.1">
            <meta name="dc.source" content="F1000Research 2020 9:662">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="SMARCB1">
            <meta name="prism.keyword" content="INI1">
            <meta name="prism.keyword" content="loss of function mutation">
            <meta name="prism.keyword" content="rhabdoid">
            <meta name="prism.keyword" content="sarcoma">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2020/06/30">
            <meta name="prism.volume" content="9">
            <meta name="prism.number" content="662">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.24808.1">
            <meta name="prism.url" content="https://f1000research.com/articles/9-662">
            <meta name="citation_title" content="SMARCB1/INI1-deficient tumors of adulthood">
            <meta name="citation_abstract" content="The SMARCB1/INI1 gene was first discovered in the mid-1990&rsquo;s, and since then it has been revealed that loss of function mutations in this gene result in aggressive rhabdoid tumors. Recently, the term &ldquo;rhabdoid tumor&rdquo; has become synonymous with decreased SMARCB1/INI1 expression. When genetic aberrations in the SMARCB1/INI1 gene occur, the result can cause reduced, complete loss, and mosaic expression. Although SMARCB1/INI1-deficient tumors are predominantly sarcomas, this is a diverse group of tumors with mixed phenotypes, which can often make the diagnosis challenging. Prognosis for these aggressive tumors is often poor. Moreover, refractory and relapsing progressive disease is common. As a result, accurate and timely diagnosis is imperative. Despite the SMARCB1/INI1 gene itself and its implications in tumorigenesis being discovered over two decades ago, there is a paucity of rhabdoid tumor cases reported in the literature that detail SMARCB1/INI1 expression. Much work remains if we hope to provide additional therapeutic strategies for patients with aggressive SMARCB1/INI1-deficient tumors.">
            <meta name="citation_description" content="The SMARCB1/INI1 gene was first discovered in the mid-1990&rsquo;s, and since then it has been revealed that loss of function mutations in this gene result in aggressive rhabdoid tumors. Recently, the term &ldquo;rhabdoid tumor&rdquo; has become synonymous with decreased SMARCB1/INI1 expression. When genetic aberrations in the SMARCB1/INI1 gene occur, the result can cause reduced, complete loss, and mosaic expression. Although SMARCB1/INI1-deficient tumors are predominantly sarcomas, this is a diverse group of tumors with mixed phenotypes, which can often make the diagnosis challenging. Prognosis for these aggressive tumors is often poor. Moreover, refractory and relapsing progressive disease is common. As a result, accurate and timely diagnosis is imperative. Despite the SMARCB1/INI1 gene itself and its implications in tumorigenesis being discovered over two decades ago, there is a paucity of rhabdoid tumor cases reported in the literature that detail SMARCB1/INI1 expression. Much work remains if we hope to provide additional therapeutic strategies for patients with aggressive SMARCB1/INI1-deficient tumors.">
            <meta name="citation_keywords" content="SMARCB1, INI1, loss of function mutation, rhabdoid, sarcoma">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Nathaniel A. Parker">
            <meta name="citation_author_institution" content="University of Kansas School of Medicine, 1010 N Kansas St, Wichita, KS, 67214, USA">
            <meta name="citation_author" content="Ammar Al-Obaidi">
            <meta name="citation_author_institution" content="University of Kansas School of Medicine, 1010 N Kansas St, Wichita, KS, 67214, USA">
            <meta name="citation_author" content="Jeremy M. Deutsch">
            <meta name="citation_author_institution" content="Cancer Center of Kansas, 818 N. Emporia #403, Wichita, KS, 67214, USA">
            <meta name="citation_publication_date" content="2020/06/30">
            <meta name="citation_volume" content="9">
            <meta name="citation_publication_number" content="662">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.24808.1">
            <meta name="citation_firstpage" content="662">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/9-662/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/9-662.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=27370 /> <input type=hidden id=articleId name=articleId value=24808 /> <input type=hidden id=xmlUrl value="/articles/9-662/v1/xml"/> <input type=hidden id=xmlFileName value="-9-662-v1.xml"> <input type=hidden id=article_uuid value=52ca814f-5586-4ab7-b688-8d2e83c0d799 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="SMARCB1/INI1-deficient tumors of adulthood"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.24808.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.24808.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/9-662"
  },
  "headline": "SMARCB1/INI1-deficient tumors of adulthood",
  "datePublished": "2020-06-30T15:46:31",
  "dateModified": "2020-06-30T15:46:31",
  "author": [
    {
      "@type": "Person",
      "name": "Nathaniel A. Parker"
    },    {
      "@type": "Person",
      "name": "Ammar Al-Obaidi"
    },    {
      "@type": "Person",
      "name": "Jeremy M. Deutsch"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The SMARCB1/INI1 gene was first discovered in the mid-1990&rsquo;s, and since then it has been revealed that loss of function mutations in this gene result in aggressive rhabdoid tumors. Recently, the term &ldquo;rhabdoid tumor&rdquo; has become synonymous with decreased SMARCB1/INI1 expression. When genetic aberrations in the SMARCB1/INI1 gene occur, the result can cause reduced, complete loss, and mosaic expression. Although SMARCB1/INI1-deficient tumors are predominantly sarcomas, this is a diverse group of tumors with mixed phenotypes, which can often make the diagnosis challenging. Prognosis for these aggressive tumors is often poor. Moreover, refractory and relapsing progressive disease is common. As a result, accurate and timely diagnosis is imperative. Despite the SMARCB1/INI1 gene itself and its implications in tumorigenesis being discovered over two decades ago, there is a paucity of rhabdoid tumor cases reported in the literature that detail SMARCB1/INI1 expression. Much work remains if we hope to provide additional therapeutic strategies for patients with aggressive SMARCB1/INI1-deficient tumors."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/9-662",
            "name": "SMARCB1/INI1-deficient tumors of adulthood"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> SMARCB1/INI1-deficient tumors of adulthood </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=27370 data-id=24808 data-downloads="" data-views="" data-scholar="10.12688/f1000research.24808.1" data-recommended="" data-doi="10.12688/f1000research.24808.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/9-662/v1/pdf?article_uuid=52ca814f-5586-4ab7-b688-8d2e83c0d799" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-24808-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-24808-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-24808-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Parker NA, Al-Obaidi A and Deutsch JM. SMARCB1/INI1-deficient tumors of adulthood [version 1; peer review: awaiting peer review]</span>. <i>F1000Research</i> 2020, <b>9</b>:662 (<a class=new-orange href="https://doi.org/10.12688/f1000research.24808.1" target=_blank>https://doi.org/10.12688/f1000research.24808.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-24808-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=24808 id=track-article-signin-24808 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/24808?target=/articles/9-662">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=27370 /> <input name=articleId type=hidden value=24808 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>SMARCB1/INI1-deficient tumors of adulthood</h1><span class=other-info> [version 1; peer review: awaiting peer review]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:naparker1031@gmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Nathaniel A. Parker</span></a><a href="https://orcid.org/0000-0002-5519-7758" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5519-7758</div><sup>1</sup>,&nbsp;</span><span class="">Ammar Al-Obaidi<a href="https://orcid.org/0000-0001-5946-393X" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5946-393X</div><sup>1</sup>,&nbsp;</span><span class="">Jeremy M. Deutsch<sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:naparker1031@gmail.com" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Nathaniel A. Parker</span></a><a href="http://orcid.org/0000-0002-5519-7758" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-5519-7758</div><sup>1</sup>,&nbsp;</span><span class="">Ammar Al-Obaidi<a href="http://orcid.org/0000-0001-5946-393X" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5946-393X</div><sup>1</sup>,&nbsp;</span><span class="">Jeremy M. Deutsch<sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 30 Jun 2020 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.24808.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> University of Kansas School of Medicine, 1010 N Kansas St, Wichita, KS, 67214, USA<br/> <sup>2</sup> Cancer Center of Kansas, 818 N. Emporia #403, Wichita, KS, 67214, USA<br/> <p> <div class=margin-bottom> Nathaniel A. Parker <br/> <span>Roles: </span> Conceptualization, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Ammar Al-Obaidi <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Jeremy M. Deutsch <br/> <span>Roles: </span> Supervision </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <em>AWAITING PEER REVIEW</em> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The <i>SMARCB1/INI1</i> gene was first discovered in the mid-1990’s, and since then it has been revealed that loss of function mutations in this gene result in aggressive rhabdoid tumors. Recently, the term “rhabdoid tumor” has become synonymous with decreased <i>SMARCB1/INI1</i> expression. When genetic aberrations in the <i>SMARCB1/INI1</i> gene occur, the result can cause reduced, complete loss, and mosaic expression. Although SMARCB1/INI1-deficient tumors are predominantly sarcomas, this is a diverse group of tumors with mixed phenotypes, which can often make the diagnosis challenging. Prognosis for these aggressive tumors is often poor. Moreover, refractory and relapsing progressive disease is common. As a result, accurate and timely diagnosis is imperative. Despite the <i>SMARCB1/INI1</i> gene itself and its implications in tumorigenesis being discovered over two decades ago, there is a paucity of rhabdoid tumor cases reported in the literature that detail <i>SMARCB1/INI1</i> expression. Much work remains if we hope to provide additional therapeutic strategies for patients with aggressive SMARCB1/INI1-deficient tumors. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> SMARCB1, INI1, loss of function mutation, rhabdoid, sarcoma </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Nathaniel A. Parker (<a href="mailto:naparker1031@gmail.com">naparker1031@gmail.com</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Nathaniel A. Parker </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2020 Parker NA <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Parker NA, Al-Obaidi A and Deutsch JM. SMARCB1/INI1-deficient tumors of adulthood [version 1; peer review: awaiting peer review]</span>. <i>F1000Research</i> 2020, <b>9</b>:662 (<a href="https://doi.org/10.12688/f1000research.24808.1" target=_blank>https://doi.org/10.12688/f1000research.24808.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 30 Jun 2020, <b>9</b>:662 (<a href="https://doi.org/10.12688/f1000research.24808.1" target=_blank>https://doi.org/10.12688/f1000research.24808.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 30 Jun 2020, <b>9</b>:662 (<a href="https://doi.org/10.12688/f1000research.24808.1" target=_blank>https://doi.org/10.12688/f1000research.24808.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d21564e178>History of the <i>SMARCB1/INI1</i> Gene</h2><p class="" id=d21564e184>SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1), also known as integrase interactor 1 (INI1), is a crucial component of a chromatin-remodeling protein complex. <i>SMARCB1/INI1</i> was first identified in yeast in the late 1980’s<sup><a href="#ref-1">1</a></sup>. By 1994, its human homologue was isolated in fibroblast cells<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. Subsequent molecular investigations showed this nuclear protein complex enhances DNA transcription by interactions with HIV-1 integrase<sup><a href="#ref-2">2</a></sup>. Nuclear <i>SMARCB1/INI1</i> exists ubiquitously in all normal cells, and acts as a tumor suppressor gene<sup><a href="#ref-4">4</a></sup>. It was revealed in the early 2000’s by studies in mice that biallelic knockout of the <i>SMARCB1/INI1</i> gene resulted in early lethality<sup><a href="#ref-5">5</a></sup>. Mice with heterozygous loss before birth, or who had later conditional single-allele knockout after birth, of <i>SMARCB1/INI1</i> developed aggressive rhabdoid tumors<sup><a href="#ref-6">6</a>–<a href="#ref-8">8</a></sup>. Since its discovery, much work has revealed this chromatin-remodeling protein has crucial roles in multiple signaling pathways that function to suppress tumorigenesis and tumor growth<sup><a href="#ref-9">9</a></sup>. Although these pathways are highly complex, the development and use of targeted anti-cancer therapies has practically become ubiquitous for nearly all solid tumors. Thus, continued investigations are needed if we hope to provide additional therapeutic strategies for patients with aggressive SMARCB1/INI1-deficient tumors<sup><a href="#ref-9">9</a></sup>. </p><p class="" id=d21564e239>Interestingly, the genetic signatures of SMARCB1/INI1-deficient tumors are far from monotonous. Three distinct patterns of abnormal <i>SMARCB1/INI1</i> gene expression have been identified – reduced, complete loss, and mosaic<sup><a href="#ref-9">9</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21564e252>Epidemiology, clinical, prognosis</h2><p class="" id=d21564e255>Complete loss of <i>SMARCB1/INI1</i> expression has been linked to a number of pediatric and adult sarcomas (<a href="#T1">Table 1</a>). Malignant rhabdoid tumor (MRT) and epithelioid sarcoma (ES) both result from biallelic deletions or mutations causing a complete loss of <i>SMARCB1/INI1</i> expression<sup><a href="#ref-41">41</a></sup>. Commonly arising before the age of three years old, MRTs are considered one of the most aggressive childhood neoplasms associated with high mortality<sup><a href="#ref-41">41</a></sup>. MRTs have been reported in adults<sup><a href="#ref-42">42</a>–<a href="#ref-49">49</a></sup>. Based on MRT of adulthood being primarily reported anecdotally, estimated rates of incidence remain unclear. Data concerning the 5-year survival rate for MRT in adults is difficult to determine as well, as various percentages have been reported in literature<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>. However, estimated average survival following MRT diagnosis has been reported to be six months<sup><a href="#ref-10">10</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Epidemiologic, selected clinical, and prognostic data for SMARCB1/INI1-deficient tumors.</h3><p id=d21564e304>STS, soft tissue sarcomas; MRT, malignant rhabdoid tumor; MPNST, malignant peripheral nerve sheath tumor; NF-1, neurofibromatosis type 1; NF-2; neurofibromatosis type 2, GI, gastrointestinal; NA, data not available.</p></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d21564e308 class=n-a></a><thead><a name=d21564e310 class=n-a></a><tr><a name=d21564e312 class=n-a></a><th align=center colspan=1 rowspan=1 valign=top><a name=d21564e314 class=n-a></a></th><th align=center colspan=1 rowspan=1 valign=top><a name=d21564e316 class=n-a></a></th><th align=center colspan=1 rowspan=1 valign=top><a name=d21564e318 class=n-a></a>Epidemiology, Clinical</th><th align=center colspan=1 rowspan=1 valign=top><a name=d21564e321 class=n-a></a>Survival</th></tr></thead><tbody><a name=d21564e326 class=n-a></a><tr><a name=d21564e328 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e330 class=n-a></a>Reduced<br class=br>expression</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e335 class=n-a></a>Synovial sarcoma</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e338 class=n-a></a>5 – 10% of all STS; median age of 40 years;<br class=br>males<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e349 class=n-a></a>5-year, 36–76%<sup><a href="#ref-11">11</a></sup></td></tr><tr><a name=d21564e356 class=n-a></a><td align=left colspan=1 rowspan=11 valign=middle><a name=d21564e358 class=n-a></a>Complete loss</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e361 class=n-a></a>Malignant rhabdoid<br class=br>tumor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e366 class=n-a></a>Typically &lt; 3 years of age<sup><a href="#ref-11">11</a></sup>; typically presents in<br class=br>intraabdominally in adult males<sup><a href="#ref-10">10</a>,<a href="#ref-12">12</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e381 class=n-a></a>MRT: 5-year, 15 – 20%<sup><a href="#ref-13">13</a></sup>;<br class=br>extrarenal rhabdoid<br class=br>tumor: 5-year, 35%<sup><a href="#ref-14">14</a></sup></td></tr><tr><a name=d21564e396 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e398 class=n-a></a>Atypical teratoid/<br class=br>rhabdoid tumor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e403 class=n-a></a>Typically &lt; 3 years of age; 10% of CNS tumors in<br class=br>infants<sup><a href="#ref-12">12</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e411 class=n-a></a>20 months<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup></td></tr><tr><a name=d21564e421 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e423 class=n-a></a>Epithelioid sarcoma</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e426 class=n-a></a>&lt; 1% of all STS; median age of 27 years, males<sup><a href="#ref-17">17</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e432 class=n-a></a>5-year, 68% (all ages)<sup><a href="#ref-18">18</a></sup></td></tr><tr><a name=d21564e439 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e441 class=n-a></a>Renal medullary<br class=br>carcinoma</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e446 class=n-a></a>Third most common kidney cancer among children<br class=br>and young adults; median age of 28 years; males<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e457 class=n-a></a>Overall survival less<br class=br>than 12 months<sup><a href="#ref-19">19</a></sup></td></tr><tr><a name=d21564e467 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e469 class=n-a></a>Epithelioid malignant<br class=br>peripheral nerve sheath<br class=br>tumor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e476 class=n-a></a>&lt; 1% of all STS; &lt; 5% of all MPNSTs; aggressive<br class=br>MPNST variant; unlike MPNST uncommonly<br class=br>associated with NF-1; median age &gt; 40 years<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e489 class=n-a></a>5-year, 34 – 43%<sup><a href="#ref-22">22</a></sup></td></tr><tr><a name=d21564e496 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e498 class=n-a></a>Myoepithelial carcinoma</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e501 class=n-a></a>About 70% occur in parotid gland; median age of<br class=br>55 years<sup><a href="#ref-23">23</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e509 class=n-a></a>5-year, 71%<sup><a href="#ref-24">24</a></sup></td></tr><tr><a name=d21564e516 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e518 class=n-a></a>Extraskeletal myxoid<br class=br>chondrosarcoma</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e523 class=n-a></a>&lt; 3% of all STS; median age of 50 years; males<sup><a href="#ref-25">25</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e529 class=n-a></a>5-year, 80 – 90%<sup><a href="#ref-25">25</a></sup></td></tr><tr><a name=d21564e536 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e538 class=n-a></a>Chordoma</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e541 class=n-a></a>Median age of 50 – 60 years in adults, males;<br class=br>median age of 10 – 12 years in children, females<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e552 class=n-a></a>5-year, 70%<sup><a href="#ref-28">28</a></sup></td></tr><tr><a name=d21564e559 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e561 class=n-a></a>Pancreas<br class=br>undifferentiated<br class=br>rhabdoid carcinoma</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e568 class=n-a></a>Heterogeneous group of neoplasms; poorly<br class=br>characterized<sup><a href="#ref-29">29</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e576 class=n-a></a>NA</td></tr><tr><a name=d21564e580 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e582 class=n-a></a>Sinonasal basaloid<br class=br>carcinoma</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e587 class=n-a></a>&lt; 5% of all head/neck cancers; 0.5 cases per<br class=br>100,000 population per year; males<sup><a href="#ref-30">30</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e595 class=n-a></a>Median overall survival<br class=br>17 months<sup><a href="#ref-31">31</a></sup></td></tr><tr><a name=d21564e605 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e607 class=n-a></a>Rhabdoid carcinoma of<br class=br>the gastrointestinal tract</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e612 class=n-a></a>About 0.1% of all gastric cancers; &lt; 50 cases<br class=br>reported in the upper and lower GI tract<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e623 class=n-a></a>Overall survival six<br class=br>months<sup><a href="#ref-33">33</a></sup></td></tr><tr><a name=d21564e632 class=n-a></a><td align=left colspan=1 rowspan=3 valign=middle><a name=d21564e634 class=n-a></a>Mosaic<br class=br>expression</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e639 class=n-a></a>Schwannomatosis</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e642 class=n-a></a>Third major form of neurofibromatosis; distinct<br class=br>from NF-1 and NF-2; median age of 40 years; 20%<br class=br>familial<sup><a href="#ref-34">34</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e652 class=n-a></a>NA</td></tr><tr><a name=d21564e656 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e658 class=n-a></a>Gastrointestinal stromal<br class=br>tumor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e663 class=n-a></a>5% of all STS, 80% of all mesenchymal GI tract<br class=br>tumors; median age of 60 years<sup><a href="#ref-35">35</a>–<a href="#ref-37">37</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e674 class=n-a></a>5-year, 83%<sup><a href="#ref-38">38</a></sup></td></tr><tr><a name=d21564e681 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e683 class=n-a></a>Ossifying fibromyxoid<br class=br>tumor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e688 class=n-a></a>Only 300 cases reported worldwide; median age of<br class=br>50 years; males<sup><a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e699 class=n-a></a>NA</td></tr></tbody></table></div><p class="" id=d21564e706>ES is now categorized into two subgroups: distal and proximal. Conventional or distal-type ES tends to be histologically similar squamous cells. Also, distal-type ES immunohistochemical (IHC) profiles can be diverse. Proximal-type ES is thought to be the more aggressive variant, and has an affinity for the proximal limbs of young adults. Microscopically, sheets of large rhabdoid tumor cells are predominantly observed<sup><a href="#ref-50">50</a></sup>. Based on more recent clinicopathologic and IHC data, many tumors that were previously diagnosed as a MRT are now classified as proximal ES<sup><a href="#ref-51">51</a></sup>.</p><p class="" id=d21564e717>In addition to ES, atypical teratoid/rhabdoid tumor, renal medullary carcinoma, and pediatric chordoma are rare sarcomas that result from the complete loss of <i>SMARCB1/INI1</i> expression (<a href="#T1">Table 1</a>). They predominantly occur in pediatric or young adult patients. Collectively, these neoplasms typically develop in the head/neck, CNS, thorax, kidneys, other visceral organs, retroperitoneum, trunk, and extremities<sup><a href="#ref-12">12</a>,<a href="#ref-17">17</a>,<a href="#ref-19">19</a>,<a href="#ref-26">26</a>,<a href="#ref-52">52</a></sup>. Exceedingly rare SMARCB1/INI1-deficient tumors that occur more commonly in adults include synovial sarcomas, epithelioid malignant peripheral nerve sheath tumor, myoepithelial carcinoma, extraskeletal myxoid chondrosarcoma, chordoma, schwannomatosis, gastrointestinal stromal tumors (GIST), and ossifying fibromyxoid tumor (<a href="#T1">Table 1</a>). On light microscopy, these sarcomatous neoplasms exist on a morphological spectrum. Tissue specimens are often composed of epithelioid or rhabdoid cells<sup><a href="#ref-53">53</a></sup>. However, other morphologic patterns have been described<sup><a href="#ref-50">50</a></sup>. Thus, the diagnosis of SMARCB1/INI1-deficient tumors can be difficult based on their polyphenotypic variation<sup><a href="#ref-4">4</a></sup>. SMARCB1/INI1 immunostaining can be used to confirm the diagnosis of an epithelioid or rhabdoid sarcoma because loss of <i>SMARCB1/INI1</i> expression is rarely observed in other tumor types<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>. Thus, in the absence of this genetic alteration, other malignant soft tissue tumors with epithelioid-like morphologies can be more confidently ruled out, such as melanoma, rhabdomyosarcoma, and undifferentiated carcinoma.</p><p class="" id=d21564e769>Aside from SMARCB1/INI1-deficient tumors sharing an aberration in the same gene, the relationship between these malignancies remains unclear. Following diagnosis in any age or organ, nearly all SMARCB1/INI1-deficient malignancies characteristically follow an aggressive clinical pattern and prognosis if often poor (<a href="#T1">Table 1</a>). Survival rates are often reportedly low, but they may not be accurate given low rates of incidence, and considerations for newer treatments. Also, survival can be highly dependent on surgical intervention and completeness of tumor resection, especially for chordomas. GIST are the most common sarcomas of the gastrointestinal (GI) tract. They commonly develop in the sixth decade of life and have no gender predominance<sup><a href="#ref-35">35</a></sup>. Following the diagnosis of a GIST, survival rates are highly variable and depend on specific biologic characteristics of the tumor, the type of treatment, and the risk of post-treatment recurrence<sup><a href="#ref-36">36</a></sup>. </p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21564e786>Challenges in retrospective data collection for adult cases of SMARCB1/INI-deficient tumors</h2><p class="" id=d21564e789>Recently, the term “rhabdoid tumor” has become synonymous with tumors that harbor loss of function mutations in the <i>SMARCB1/INI1</i> gene<sup><a href="#ref-56">56</a></sup>. We reviewed the literature and found a paucity of cases reporting <i>SMARCB1/INI1</i> genetic aberrations in adult patients with sarcomas. A total of 450 cases of rare sarcomas were found to be described in single case reports, case series, or systematic reviews published between the years 2000 – 2020 (<a href="#T2">Table 2</a>)<sup><a href="#ref-57">57</a>–<a href="#ref-92">92</a></sup>. This number is likely far lower than the actual accounts of reported sarcoma cases in the literature. However, reports were excluded if it was apparent the case did not meet our inclusion criteria based on the publicly-available title or abstract information. Despite the <i>SMARCB1/INI1</i> gene being discovered in the mid-1990’s, the majority of previous reports were excluded for not mentioning the tumor’s SMARCB1/INI1-deficiency status. Also, tumor occurrence in the pediatric patient population accounted for multiple exclusions.</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Excluded rare sarcomas in adults reported in single case reports, case series, or systematic reviews, 2000–2020.</h3><p id=d21564e826>Exclusion criteria was as follows: 1.) individual patient age could not be confirmed; 2.) pediatric study population (less than 18 years of age); 3.) absence of documentation noting the loss of <i>SMARCB1/INI1</i> expression by immunohistochemistry or genetic studies; 4.) intact <i>SMARCB1/INI1</i> expression by immunochemistry or genetic studies; and 5.) non-sarcomatous histologic tumor type. PMID, PubMed Central © unique article identifier; GU, genitourinary; PNS, peripheral nervous system; GI, gastrointestinal.</p></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d21564e836 class=n-a></a><thead><a name=d21564e838 class=n-a></a><tr><a name=d21564e840 class=n-a></a><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e842 class=n-a></a>Article</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e845 class=n-a></a>PMID</th><th align=center colspan=1 rowspan=1 valign=top><a name=d21564e848 class=n-a></a>Cases,<br class=br>no.</th><th align=center colspan=1 rowspan=1 valign=top><a name=d21564e853 class=n-a></a>Tumor<br class=br>site</th><th align=center colspan=1 rowspan=1 valign=top><a name=d21564e858 class=n-a></a>Exclusion<br class=br>reason</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e864 class=n-a></a>Article</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e867 class=n-a></a>PMID</th><th align=center colspan=1 rowspan=1 valign=top><a name=d21564e870 class=n-a></a>Cases,<br class=br>no.</th><th align=center colspan=1 rowspan=1 valign=top><a name=d21564e875 class=n-a></a>Tumor<br class=br>site</th><th align=center colspan=1 rowspan=1 valign=top><a name=d21564e880 class=n-a></a>Exclusion<br class=br>reason</th></tr></thead><tbody><a name=d21564e887 class=n-a></a><tr><a name=d21564e889 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e891 class=n-a></a>Zhang <i>et al.</i>, 2019<sup><a href="#ref-57">57</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e900 class=n-a></a>31933781</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e903 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e906 class=n-a></a>scalp</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e909 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e913 class=n-a></a>Weisskopf <i>et al.</i>,<br class=br>2006<sup><a href="#ref-75">75</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e924 class=n-a></a>16474944</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e927 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e930 class=n-a></a>spine</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e933 class=n-a></a>2,3</td></tr><tr><a name=d21564e937 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e939 class=n-a></a>Kubota <i>et al.</i>, 2019<sup><a href="#ref-58">58</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e948 class=n-a></a>31034722</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e951 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e954 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e957 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e961 class=n-a></a>Onol <i>et al.</i>, 2006<sup><a href="#ref-76">76</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e970 class=n-a></a>16343734</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e973 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e976 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e979 class=n-a></a>3</td></tr><tr><a name=d21564e983 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e985 class=n-a></a>Kolin <i>et al.</i>, 2018<sup><a href="#ref-59">59</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e994 class=n-a></a>29700418</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e997 class=n-a></a>5</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1000 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1003 class=n-a></a>4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1007 class=n-a></a>Zevallos-G. <i>et al.</i>,<br class=br>2005<sup><a href="#ref-77">77</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1018 class=n-a></a>16082246</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1021 class=n-a></a>2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1024 class=n-a></a>perineum </td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1027 class=n-a></a>3</td></tr><tr><a name=d21564e1031 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1033 class=n-a></a>Kim <i>et al.</i>, 2018<sup><a href="#ref-60">60</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1042 class=n-a></a>30235775</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1045 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1048 class=n-a></a>brain</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1051 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1055 class=n-a></a>Masunaga <i>et al.</i>,<br class=br>2004<sup><a href="#ref-78">78</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1066 class=n-a></a>15260853</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1069 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1072 class=n-a></a>lung</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1075 class=n-a></a>3</td></tr><tr><a name=d21564e1079 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1081 class=n-a></a>Strehl <i>et al.</i>, 2015<sup><a href="#ref-61">61</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1090 class=n-a></a>25920939</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1093 class=n-a></a>25</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1096 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1099 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1103 class=n-a></a>Chang <i>et al.</i>, 2004<sup><a href="#ref-79">79</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1112 class=n-a></a>14713833</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1115 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1118 class=n-a></a>GI</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1121 class=n-a></a>2</td></tr><tr><a name=d21564e1126 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1128 class=n-a></a>Santos <i>et al.</i>, 2013<sup><a href="#ref-62">62</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1137 class=n-a></a>23793215</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1140 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1143 class=n-a></a>pelvis</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1146 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1150 class=n-a></a>Altundag <i>et al.</i>, 2004<sup><a href="#ref-80">80</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1159 class=n-a></a>15579921</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1162 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1165 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1168 class=n-a></a>3</td></tr><tr><a name=d21564e1172 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1174 class=n-a></a>Patrizi <i>et al.</i>, 2013<sup><a href="#ref-63">63</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1183 class=n-a></a>23886403</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1186 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1189 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1192 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1196 class=n-a></a>Lee <i>et al.</i>, 2004<sup><a href="#ref-81">81</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1205 class=n-a></a>14675288</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1208 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1211 class=n-a></a>pelvis</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1214 class=n-a></a>3</td></tr><tr><a name=d21564e1218 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1220 class=n-a></a>Zhao <i>et al.</i>, 2013<sup><a href="#ref-49">49</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1229 class=n-a></a>23761028</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1232 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1235 class=n-a></a>renal</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1238 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1242 class=n-a></a>Peng <i>et al.</i>, 2003<sup><a href="#ref-44">44</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1251 class=n-a></a>12946214</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1254 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1257 class=n-a></a>renal</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1260 class=n-a></a>3</td></tr><tr><a name=d21564e1264 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1266 class=n-a></a>Tocco <i>et al.</i>, 2012<sup><a href="#ref-64">64</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1275 class=n-a></a>23359842</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1278 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1281 class=n-a></a>scalp</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1284 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1288 class=n-a></a>Hanna <i>et al.</i>, 2002<sup><a href="#ref-82">82</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1297 class=n-a></a>12107573</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1300 class=n-a></a>8</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1303 class=n-a></a>multiple </td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1306 class=n-a></a>3</td></tr><tr><a name=d21564e1310 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1312 class=n-a></a>Rizzo <i>et al.</i>, 2012<sup><a href="#ref-65">65</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1321 class=n-a></a>22614000</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1324 class=n-a></a>12</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1327 class=n-a></a>PNS</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1330 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1334 class=n-a></a>Etienne-M. <i>et al.</i>,<br class=br>2002<sup><a href="#ref-83">83</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1345 class=n-a></a>12445750</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1348 class=n-a></a>12</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1351 class=n-a></a>multiple </td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1354 class=n-a></a>3,5</td></tr><tr><a name=d21564e1358 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1360 class=n-a></a>Kuge <i>et al.</i>, 2012<sup><a href="#ref-66">66</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1369 class=n-a></a>22218708</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1372 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1375 class=n-a></a>brain</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1378 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1382 class=n-a></a>Moore <i>et al.</i>, 2002<sup><a href="#ref-84">84</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1391 class=n-a></a>11925150</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1394 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1397 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1400 class=n-a></a>3</td></tr><tr><a name=d21564e1405 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1407 class=n-a></a>Hagström <i>et al.</i>,<br class=br>2011<sup><a href="#ref-67">67</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1418 class=n-a></a>21420628</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1421 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1424 class=n-a></a>oral </td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1427 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1431 class=n-a></a>Haidopoulos <i>et al.</i>,<br class=br>2002<sup><a href="#ref-85">85</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1441 class=n-a></a>12440823</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1444 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1447 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1450 class=n-a></a>3</td></tr><tr><a name=d21564e1454 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1456 class=n-a></a>Narendra <i>et al.</i>,<br class=br>2010<sup><a href="#ref-68">68</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1467 class=n-a></a>20479553</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1470 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1473 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1476 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1480 class=n-a></a>Tzilinis <i>et al.</i>, 2002<sup><a href="#ref-86">86</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1489 class=n-a></a>16093195</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1492 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1495 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1498 class=n-a></a>3</td></tr><tr><a name=d21564e1502 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1504 class=n-a></a>Tholpady <i>et al.</i>,<br class=br>2010<sup><a href="#ref-69">69</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1515 class=n-a></a>20881848</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1518 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1521 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1524 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1528 class=n-a></a>Amrikachi <i>et al.</i>,<br class=br>2002<sup><a href="#ref-87">87</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1539 class=n-a></a>12478486</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1542 class=n-a></a>4</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1545 class=n-a></a>GI</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1548 class=n-a></a>3</td></tr><tr><a name=d21564e1552 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1554 class=n-a></a>Chbani <i>et al.</i>, 2009<sup><a href="#ref-55">55</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1563 class=n-a></a>19141382</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1566 class=n-a></a>106</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1569 class=n-a></a>multiple </td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1572 class=n-a></a>1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1576 class=n-a></a>Hasegawa <i>et al.</i>,<br class=br>2001<sup><a href="#ref-88">88</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1587 class=n-a></a>11454997</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1590 class=n-a></a>20</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1593 class=n-a></a>multiple </td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1596 class=n-a></a>3</td></tr><tr><a name=d21564e1600 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1602 class=n-a></a>Hornick <i>et al.</i>,<br class=br>2009<sup><a href="#ref-70">70</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1613 class=n-a></a>19033866</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1616 class=n-a></a>127</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1619 class=n-a></a>multiple </td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1622 class=n-a></a>1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1626 class=n-a></a>Kasamatsu <i>et al.</i>,<br class=br>2001<sup><a href="#ref-89">89</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1637 class=n-a></a>11520372</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1640 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1643 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1646 class=n-a></a>3</td></tr><tr><a name=d21564e1650 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1652 class=n-a></a>Kim <i>et al.</i>, 2008<sup><a href="#ref-71">71</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1661 class=n-a></a>19471567</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1664 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1667 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1670 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1674 class=n-a></a>Knapik <i>et al.</i>, 2001<sup><a href="#ref-90">90</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1683 class=n-a></a>11521235</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1686 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1689 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1692 class=n-a></a>4</td></tr><tr><a name=d21564e1697 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1699 class=n-a></a>Rekhi <i>et al.</i>, 2008<sup><a href="#ref-72">72</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1708 class=n-a></a>18607629</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1711 class=n-a></a>40</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1714 class=n-a></a>multiple </td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1717 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1721 class=n-a></a>Biegal <i>et al.</i>, 2000<sup><a href="#ref-91">91</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1730 class=n-a></a>10738300</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1733 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1736 class=n-a></a>brain</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1739 class=n-a></a>2</td></tr><tr><a name=d21564e1743 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1745 class=n-a></a>Argenta <i>et al.</i>,<br class=br>2007<sup><a href="#ref-73">73</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1756 class=n-a></a>17692365</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1759 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1762 class=n-a></a>GU</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1765 class=n-a></a>3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1769 class=n-a></a>Spillane <i>et al.</i>, 2000<sup><a href="#ref-92">92</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1778 class=n-a></a>10791853</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1781 class=n-a></a>37</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1784 class=n-a></a>multiple </td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1787 class=n-a></a>3</td></tr><tr><a name=d21564e1791 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1793 class=n-a></a>Bourdeaut<br class=br><i>et al.</i>, 2007<sup><a href="#ref-74">74</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1803 class=n-a></a>17152049</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1806 class=n-a></a>26</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1809 class=n-a></a>multiple</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1812 class=n-a></a>2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1816 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1818 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1820 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1822 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1824 class=n-a></a></td></tr></tbody></table></div><p class="" id=d21564e1830>We located 25 cases of adult SMARCB1/INI1-deficient sarcomas that were described in 18 reports (<a href="#T3">Table 3</a>)<sup><a href="#ref-42">42</a>,<a href="#ref-50">50</a>,<a href="#ref-93">93</a>–<a href="#ref-108">108</a></sup>. Median age at the time of diagnosis was 36 years old. A male predominance was mildly observed (14 cases, 56%), which is consistent with other larger reviews. Presentation in the head and neck (e.g. brain, eye, nose, and scalp) occurred more frequently (6 cases, 24%). No descriptive data analysis was performed to determine if our observations were significant. The majority of reports were originally described as proximal epithelioid sarcoma, but overall these remained a morphologically diverse group of cases that also included rhabdoid and mixed phenotypes.</p><a name=T3 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 3. Included rare sarcomas reported in single case reports, case series, or systematic reviews, 2000–2020.</h3><p id=d21564e1859>Inclusion criteria was as follows: ability to confirm an individual case patient was greater than 18 years of age; documentation of a loss of <i>SMARCB1/INI1</i> expression by immunohistochemistry or genetic studies; and confirmed sarcomatous histologic tumor type. “ - “ denotes complete, reduced, or mosaic loss of <i>SMARCB1/INI1</i> expression (exp.). M, male; F, female.</p></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d21564e1869 class=n-a></a><thead><a name=d21564e1871 class=n-a></a><tr><a name=d21564e1873 class=n-a></a><th align=left colspan=1 rowspan=1 valign=middle><a name=d21564e1875 class=n-a></a>Article</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e1878 class=n-a></a>PMID</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e1881 class=n-a></a>Cases,<br class=br>no.</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e1886 class=n-a></a>Age,<br class=br>Sex</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e1891 class=n-a></a>Tumor site</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e1895 class=n-a></a>SMARCB1/ INI1<br class=br>exp.</th><th align=left colspan=1 rowspan=1 valign=middle><a name=d21564e1900 class=n-a></a>Sarcoma morphology</th></tr></thead><tbody><a name=d21564e1905 class=n-a></a><tr><a name=d21564e1907 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1909 class=n-a></a>Parker <i>et al.</i>, 2020<sup><a href="#ref-42">42</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1918 class=n-a></a>32467817</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1921 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1924 class=n-a></a>56 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1927 class=n-a></a>inguinal</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1931 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1934 class=n-a></a>epithelioid, rhabdoid</td></tr><tr><a name=d21564e1938 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1940 class=n-a></a>Ahmad <i>et al.</i>, 2019<sup><a href="#ref-93">93</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1949 class=n-a></a>31737506</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1952 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1955 class=n-a></a>27 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1958 class=n-a></a>pleura</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1962 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1965 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e1969 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1971 class=n-a></a>Bodi <i>et al.</i>, 2018<sup><a href="#ref-94">94</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1980 class=n-a></a>29541486</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1983 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1986 class=n-a></a>22 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1989 class=n-a></a>brain</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e1993 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e1996 class=n-a></a>epithelioid, spindle-shaped</td></tr><tr><a name=d21564e2000 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2002 class=n-a></a>Gurwale <i>et al.</i>, 2017<sup><a href="#ref-95">95</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2011 class=n-a></a>-</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2014 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2017 class=n-a></a>18 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2020 class=n-a></a>scalp</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2024 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2027 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2031 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2033 class=n-a></a>Saha D <i>et al.</i>, 2016<sup><a href="#ref-96">96</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2042 class=n-a></a>27045049</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2045 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2048 class=n-a></a>41 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2051 class=n-a></a>lung</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2055 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2058 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2063 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2065 class=n-a></a>Rego <i>et al.</i>, 2015<sup><a href="#ref-97">97</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2074 class=n-a></a>25737787</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2077 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2080 class=n-a></a>34 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2083 class=n-a></a>vulva</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2087 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2090 class=n-a></a>epithelioid, spindle-shaped</td></tr><tr><a name=d21564e2094 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2096 class=n-a></a>Wetzel <i>et al.</i>, 2014<sup><a href="#ref-98">98</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2105 class=n-a></a>24997629</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2108 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2111 class=n-a></a>51 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2114 class=n-a></a>oral</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2118 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2121 class=n-a></a>rhabdoid</td></tr><tr><a name=d21564e2125 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2127 class=n-a></a>Agaimy <i>et al.</i>, 2014<sup><a href="#ref-99">99</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2136 class=n-a></a>24503755</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2139 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2142 class=n-a></a>66 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2145 class=n-a></a>stomach</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2149 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2152 class=n-a></a>rhabdoid</td></tr><tr><a name=d21564e2156 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2158 class=n-a></a>Madsen <i>et al.</i>, 2013<sup><a href="#ref-100">100</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2167 class=n-a></a>24457248</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2170 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2173 class=n-a></a>45 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2176 class=n-a></a>pleura</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2180 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2183 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2187 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2189 class=n-a></a>Frank <i>et al.</i>, 2013<sup><a href="#ref-101">101</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2198 class=n-a></a>24308011</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2201 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2204 class=n-a></a>43 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2207 class=n-a></a>eye</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2211 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2214 class=n-a></a>epithelioid, spindle-shaped</td></tr><tr><a name=d21564e2218 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2220 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2222 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2224 class=n-a></a>2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2227 class=n-a></a>71 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2230 class=n-a></a>nasal</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2234 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2237 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2242 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2244 class=n-a></a>Kim <i>et al.</i> 2012<sup><a href="#ref-102">102</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2253 class=n-a></a>21724432</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2256 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2259 class=n-a></a>41 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2262 class=n-a></a>vulva</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2266 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2269 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2273 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2275 class=n-a></a>Mannan <i>et al.</i>, 2010<sup><a href="#ref-103">103</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2284 class=n-a></a>19757197</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2287 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2290 class=n-a></a>47 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2293 class=n-a></a>inguinal</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2297 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2300 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2304 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2306 class=n-a></a>Takei <i>et al.</i>, 2010<sup><a href="#ref-104">104</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2315 class=n-a></a>19911885</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2318 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2321 class=n-a></a>33 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2324 class=n-a></a>brain</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2328 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2331 class=n-a></a>rhabdoid</td></tr><tr><a name=d21564e2335 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2337 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2339 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2341 class=n-a></a>2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2344 class=n-a></a>79 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2347 class=n-a></a>cecum</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2351 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2354 class=n-a></a>rhabdoid</td></tr><tr><a name=d21564e2358 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2360 class=n-a></a>Raoux <i>et al.</i>, 2009<sup><a href="#ref-105">105</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2369 class=n-a></a>19342946</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2372 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2375 class=n-a></a>31 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2378 class=n-a></a>bone</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2382 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2385 class=n-a></a>epithelioid, spindle-shaped</td></tr><tr><a name=d21564e2389 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2391 class=n-a></a>Robbens <i>et al.</i>, 2006<sup><a href="#ref-106">106</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2400 class=n-a></a>16602014</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2403 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2406 class=n-a></a>19 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2409 class=n-a></a>vertebra</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2413 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2416 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2421 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2423 class=n-a></a>Sigauke <i>et al.</i>, 2006<sup><a href="#ref-107">107</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2432 class=n-a></a>16528370</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2435 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2438 class=n-a></a>26 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2441 class=n-a></a>wrist</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2445 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2448 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2452 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2454 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2456 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2458 class=n-a></a>2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2461 class=n-a></a>26 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2464 class=n-a></a>lymph </td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2468 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2471 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2475 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2477 class=n-a></a>Perry <i>et al.</i>, 2005<sup><a href="#ref-108">108</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2486 class=n-a></a>15761491</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2489 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2492 class=n-a></a>29 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2495 class=n-a></a>soft tissue</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2499 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2502 class=n-a></a>spindle-shaped</td></tr><tr><a name=d21564e2506 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2508 class=n-a></a>Modena <i>et al.</i>, 2005<sup><a href="#ref-50">50</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2517 class=n-a></a>15899790</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2520 class=n-a></a>1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2523 class=n-a></a>31 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2526 class=n-a></a>thigh</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2530 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2533 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2537 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2539 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2541 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2543 class=n-a></a>2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2546 class=n-a></a>47 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2549 class=n-a></a>perineum</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2553 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2556 class=n-a></a>rhabdoid</td></tr><tr><a name=d21564e2560 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2562 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2564 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2566 class=n-a></a>3</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2569 class=n-a></a>30 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2572 class=n-a></a>spine</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2576 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2579 class=n-a></a>epithelioid</td></tr><tr><a name=d21564e2584 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2586 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2588 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2590 class=n-a></a>4</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2593 class=n-a></a>36 M</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2596 class=n-a></a>spine</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2600 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2603 class=n-a></a>epithelioid, spindle-shaped</td></tr><tr><a name=d21564e2607 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2609 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2611 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2613 class=n-a></a>5</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2616 class=n-a></a>66 F</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2619 class=n-a></a>inguinal</td><td align=center colspan=1 rowspan=1 valign=top><a name=d21564e2623 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2626 class=n-a></a>epithelioid, rhabdoid</td></tr></tbody></table></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21564e2636>Treatment</h2><p class="" id=d21564e2639>Prior to, and still after, the discovery that SMARCB1/INI1-deficient tumors contribute to the large majority of soft tissue sarcomas, systemic cytotoxic agents have been used to treat this diverse group of neoplasms. Doxorubicin and ifosfamide have remained the mainstay of first-line treatment for advanced disease for the last few decades. Currently, the most widely used regimen for soft tissue sarcomas is termed AIM, which includes doxorubicin plus ifosfamide and mesna<sup><a href="#ref-109">109</a>–<a href="#ref-111">111</a></sup>. Therapies such as these, and other cytotoxic agents, exhibit intermediate to improved anti-cancer activity, and prolong survival in metastatic soft tissue sarcoma (<a href="#T4">Table 4</a>). However, refractory or progressive disease can occur. With the hopes of improving outcomes in patients who develop aggressive sarcomas, multiple new therapies are being introduced. Olaratumab, a monoclonal antibody that targets platelet-derived growth factor alpha and beta (PDGFRA/B), has been approved for first-line therapy in combination with doxorubicin due to improved progression and overall survival in sarcoma patients<sup><a href="#ref-112">112</a></sup>. The use of tyrosine kinase-inhibitors (TKIs) has transformed the treatment of advanced GIST. Imatinib, a TKI, as monotherapy is now approved for upfront treatment of metastatic GIST due to improved side effect profiles and outcomes in these patients<sup><a href="#ref-113">113</a>–<a href="#ref-115">115</a></sup>. Given its mechanism of action, imatinib is also approved for first-line treatment of the fibrosarcomatous variant of dermatofibrosarcoma protuberans<sup><a href="#ref-116">116</a>,<a href="#ref-117">117</a></sup>.</p><a name=T4 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 4. Approved first-line treatments for sarcomas.</h3><p id=d21564e2680>ORR, overall response rate; PFS, progression free survival; OS, overall survival; STS, soft tissue sarcoma; GIST, gastrointestinal stromal tumor; D, doxorubicine; I, ifosfamide; P, palifosfamide; E, Evofosfamide; T, trabectedin; O, Olaratumab; G, gemcitabine; Doc, docetaxel; NA, data not available.</p></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d21564e2684 class=n-a></a><thead><a name=d21564e2686 class=n-a></a><tr><a name=d21564e2688 class=n-a></a><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e2690 class=n-a></a>Tumor</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e2693 class=n-a></a>Drugs</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e2696 class=n-a></a>Schedules</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e2699 class=n-a></a>ORR<br class=br>(%)</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e2704 class=n-a></a>PFS<br class=br>(months)</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e2710 class=n-a></a>OS<br class=br>(months)</th><th align=center colspan=1 rowspan=1 valign=middle><a name=d21564e2715 class=n-a></a>Reference</th></tr></thead><tbody><a name=d21564e2720 class=n-a></a><tr><a name=d21564e2722 class=n-a></a><td align=left colspan=1 rowspan=10><a name=d21564e2724 class=n-a></a>STS</td><td align=left colspan=1 rowspan=5><a name=d21564e2727 class=n-a></a>Doxorubicin<br class=br><br class=br>Ifosfamide<br class=br><br class=br>Evofosfamide<br class=br><br class=br>Trabectedin<br class=br><br class=br>Olaratumab</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2743 class=n-a></a>D + I</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2746 class=n-a></a>26</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2749 class=n-a></a>7.4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2753 class=n-a></a>14.3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2756 class=n-a></a><sup><a href="#ref-128">128</a></sup></td></tr><tr><a name=d21564e2762 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2764 class=n-a></a>D + P</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2767 class=n-a></a>28.3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2770 class=n-a></a>6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2773 class=n-a></a>15.9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2776 class=n-a></a><sup><a href="#ref-129">129</a></sup></td></tr><tr><a name=d21564e2782 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2784 class=n-a></a>D + E</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2787 class=n-a></a>28.4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2790 class=n-a></a>6.3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2793 class=n-a></a>18.4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2796 class=n-a></a><sup><a href="#ref-130">130</a></sup></td></tr><tr><a name=d21564e2802 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2804 class=n-a></a>D + T</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2807 class=n-a></a>17</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2810 class=n-a></a>5.7</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2813 class=n-a></a>13.3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2816 class=n-a></a><sup><a href="#ref-131">131</a></sup></td></tr><tr><a name=d21564e2822 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2824 class=n-a></a>D + O</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2827 class=n-a></a>18.2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2830 class=n-a></a>6.6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2833 class=n-a></a>26.5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2836 class=n-a></a><sup><a href="#ref-112">112</a></sup></td></tr><tr><a name=d21564e2843 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2845 class=n-a></a>Trabectedin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2848 class=n-a></a>monotherapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2851 class=n-a></a>14.8</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2854 class=n-a></a>2.8</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2857 class=n-a></a>NA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2861 class=n-a></a><sup><a href="#ref-132">132</a></sup></td></tr><tr><a name=d21564e2867 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2869 class=n-a></a>Aldoxorubicin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2872 class=n-a></a>monotherapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2875 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2878 class=n-a></a>5.6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2881 class=n-a></a>15.8</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2885 class=n-a></a><sup><a href="#ref-133">133</a></sup></td></tr><tr><a name=d21564e2891 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2893 class=n-a></a>Amrubicin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2896 class=n-a></a>monotherapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2899 class=n-a></a>13</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2902 class=n-a></a>5.8</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2905 class=n-a></a>26</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2909 class=n-a></a><sup><a href="#ref-134">134</a></sup></td></tr><tr><a name=d21564e2915 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2917 class=n-a></a>Gemcitabine<br class=br><br class=br>Docetaxel</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2923 class=n-a></a>G + Doc</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2926 class=n-a></a>58.6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2929 class=n-a></a>5.6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2932 class=n-a></a>14.7</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2936 class=n-a></a><sup><a href="#ref-135">135</a></sup></td></tr><tr><a name=d21564e2942 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2944 class=n-a></a>Brostacillin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2947 class=n-a></a>monotherapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2950 class=n-a></a>3.9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2953 class=n-a></a>1.6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2956 class=n-a></a>NA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2960 class=n-a></a><sup><a href="#ref-136">136</a></sup></td></tr><tr><a name=d21564e2966 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2968 class=n-a></a>GIST</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2971 class=n-a></a>Imatinib</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2974 class=n-a></a>monotherapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2977 class=n-a></a>68.1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2980 class=n-a></a>18</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2984 class=n-a></a>55</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2987 class=n-a></a><sup><a href="#ref-113">113</a>–<a href="#ref-115">115</a></sup></td></tr><tr><a name=d21564e2997 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e2999 class=n-a></a>Angiosarcoma</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e3002 class=n-a></a>Paclitaxel </td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e3005 class=n-a></a>monotherapy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e3008 class=n-a></a>NA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e3011 class=n-a></a>4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e3015 class=n-a></a>8</td><td align=left colspan=1 rowspan=1 valign=top><a name=d21564e3018 class=n-a></a><sup><a href="#ref-137">137</a></sup></td></tr></tbody></table></div><p class="" id=d21564e3027>Additional TKIs have recently been introduced, with clinical trial data showing promise for their use in sarcomas. Sunitinib and regorafenib significantly improve overall survival in imatinib-resistant GIST patients<sup><a href="#ref-118">118</a></sup>. Pazopanib, a TKI that targets angiogenesis by inhibiting vascular endothelial growth factor receptor, PDGFRA/B, and KIT, has been shown to improve progression free survival in certain histologic types of sarcoma. This led to its approval for advanced, refractory non-lipomatous sarcoma<sup><a href="#ref-119">119</a>,<a href="#ref-120">120</a></sup>. Alveolar sarcomas appear to respond well to anti-angiogenetic sorafenib and cediranib<sup><a href="#ref-121">121</a>,<a href="#ref-122">122</a></sup>. In phase II studies tivozanib, which mechanism of action mimics pazopanib, exhibits promising anti-cancer activity in metastatic or nonresectable soft tissue sarcomas<sup><a href="#ref-123">123</a></sup>. </p><p class="" id=d21564e3052>Recently, much work studying the complex mechanisms involved in sarcoma tumorigenesis has revealed the potential for numerous new drug targets. Targeting mTOR by serine/threonine kinase inhibition has been widely studied. However, thus far either only equivocal or minor benefits have been shown with the administration of these agents<sup><a href="#ref-124">124</a></sup>. In contrast, phase II trial data is reassuring for the future use of palbociclib, a cyclin-dependent kinase 4 and 6 inhibitor approved in breast cancer, for liposarcoma<sup><a href="#ref-125">125</a>,<a href="#ref-126">126</a></sup>.</p><p class="" id=d21564e3067>Preliminary data from pre-clinical and phase I/II trials is encouraging for small molecule inhibitors, such as with MDM2-antagonists, histone deacetylase inhibitors, and histone methylation inhibitors<sup><a href="#ref-124">124</a></sup>. A possible breakthrough in small molecular inhibition is represented by the recent discovery of histone-lysine N-methyltransferase EZH2 upregulation in SMARCB1/INI1-deficient tumors<sup><a href="#ref-127">127</a></sup>. Given the defining characteristic of SMARCB1/INI1 deficiency in the nearly all soft tissue sarcomas, tazemetostat has emerged as a highly intriguing compound for its direct inhibition of histone-lysine N-methyltransferase EZH2<sup><a href="#ref-138">138</a>,<a href="#ref-139">139</a></sup>. Another new agent that hopes to improve outcomes for patients with these rare and aggressive SMARCB1/INI1-deficient rhabdoid sarcomas comes from the proteasome inhibitor drug class. Ixazomib selectively targets proteasomes involved in protein anabolism and cellular apoptosis, whose activity is directly enhanced by the transcription factor MYC in <i>SMARCB1/INI1</i>-deficient states. Currently, ixazomib plus gemcitabine and doxorubicin is being studied in the phase II trial setting for renal medullary carcinoma<sup><a href="#ref-140">140</a>,<a href="#ref-141">141</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21564e3098>Data availability</h2><div class=section><a name=d21564e3101 class=n-a></a><h3 class=section-title>Underlying data</h3><p class="" id=d21564e3106>No data are associated with this article.</p></div></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d21564e3114 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading is-hidden"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d22417>References</h2><div class="section ref-list"><a name=d21564e3114 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d21564e3121 class=n-a></a>Abrams E, Neigeborn L, Carlson M: Molecular analysis of SNF2 and SNF5, genes required for expression of glucose-repressible genes in Saccharomyces cerevisiae. <i>Mol Cell Biol.</i> 1986; <b>6</b>(11): 3643–3651. <a target=xrefwindow id=d21564e3129 href="http://www.ncbi.nlm.nih.gov/pubmed/3540598">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3132 href="https://doi.org/10.1128/mcb.6.11.3643">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3135 href="http://www.ncbi.nlm.nih.gov/pmc/articles/367125">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d21564e3144 class=n-a></a>Kalpana GV, Marmon S, Wang W, <i> et al.</i>: Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. <i>Science.</i> 1994; <b>266</b>(5193): 2002–2006. <a target=xrefwindow id=d21564e3155 href="http://www.ncbi.nlm.nih.gov/pubmed/7801128">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3158 href="https://doi.org/10.1126/science.7801128">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d21564e3167 class=n-a></a>Muchardt C, Sardet C, Bourachot B, <i> et al.</i>: A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. <i>Nucleic Acids Res.</i> 1995; <b>23</b>(7): 1127–1132. <a target=xrefwindow id=d21564e3178 href="http://www.ncbi.nlm.nih.gov/pubmed/7739891">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3181 href="https://doi.org/10.1093/nar/23.7.1127">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3185 href="http://www.ncbi.nlm.nih.gov/pmc/articles/306820">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d21564e3194 class=n-a></a>Hollmann TJ, Hornick JL: INI1-deficient tumors: diagnostic features and molecular genetics. <i>Am J Surg Pathol.</i> 2011; <b>35</b>(10): e47–63. <a target=xrefwindow id=d21564e3202 href="http://www.ncbi.nlm.nih.gov/pubmed/21934399">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3205 href="https://doi.org/10.1097/PAS.0b013e31822b325b">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d21564e3214 class=n-a></a>Guidi CJ, Sands AT, Zambrowicz BP, <i> et al.</i>: Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. <i>Mol Cell Biol.</i> 2001; <b>21</b>(10): 3598–3603. <a target=xrefwindow id=d21564e3225 href="http://www.ncbi.nlm.nih.gov/pubmed/11313485">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3228 href="https://doi.org/10.1128/MCB.21.10.3598-3603.2001">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3232 href="http://www.ncbi.nlm.nih.gov/pmc/articles/100281">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d21564e3242 class=n-a></a>Roberts CW, Orkin SH: The SWI/SNF complex--chromatin and cancer. <i>Nat Rev Cancer.</i> 2004; <b>4</b>(2): 133–142. <a target=xrefwindow id=d21564e3250 href="http://www.ncbi.nlm.nih.gov/pubmed/14964309">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3253 href="https://doi.org/10.1038/nrc1273">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d21564e3262 class=n-a></a>Roberts CW, Galusha SA, McMenamin ME, <i> et al.</i>: Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. <i>Proc Natl Acad Sci U S A.</i> 2000; <b>97</b>(25): 13796–13800. <a target=xrefwindow id=d21564e3273 href="http://www.ncbi.nlm.nih.gov/pubmed/11095756">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3276 href="https://doi.org/10.1073/pnas.250492697">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3280 href="http://www.ncbi.nlm.nih.gov/pmc/articles/17655">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d21564e3289 class=n-a></a>Roberts CW, Leroux MM, Fleming MD, <i> et al.</i>: Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. <i>Cancer Cell.</i> 2002; <b>2</b>(5): 415–425. <a target=xrefwindow id=d21564e3300 href="http://www.ncbi.nlm.nih.gov/pubmed/12450796">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3303 href="https://doi.org/10.1016/s1535-6108(02)00185-x">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d21564e3312 class=n-a></a>Kohashi K, Oda Y: Oncogenic roles of SMARCB1/INI1 and its deficient tumors. <i>Cancer Sci.</i> 2017; <b>108</b>(4): 547–552. <a target=xrefwindow id=d21564e3320 href="http://www.ncbi.nlm.nih.gov/pubmed/28109176">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3323 href="https://doi.org/10.1111/cas.13173">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3326 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5406539">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d21564e3335 class=n-a></a>Ferrari A, Sultan I, Huang TT, <i> et al.</i>: Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database. <i>Pediatr Blood Cancer..</i> 2011; <b>57</b>(6): 943–9. <a target=xrefwindow id=d21564e3346 href="http://www.ncbi.nlm.nih.gov/pubmed/21793180">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3349 href="https://doi.org/10.1002/pbc.23252">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3353 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4261144">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d21564e3362 class=n-a></a>Rare Soft Tissue Tumors: Synovial Sarcoma. National Cancer Institute Web site. 2019. <a target=xrefwindow id=d21564e3364 href="https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/synovial-sarcoma">Reference Source</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d21564e3374 class=n-a></a>Shonka NA, Armstrong TS, Prabhu SS, <i> et al.</i>: Atypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused review. <i>J Clin Med Res.</i> 2011; <b>3</b>(2): 85–92. <a target=xrefwindow id=d21564e3385 href="http://www.ncbi.nlm.nih.gov/pubmed/21811535">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3388 href="https://doi.org/10.4021/jocmr535w">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3392 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3140928">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d21564e3401 class=n-a></a>Doyle LA: Malignant rhabdoid tumor: Pathology of Human Disease. Academic press; 2014.</span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d21564e3410 class=n-a></a>Horazdovsky R, Manivel JC, Cheng EY: Successful salvage and long-term survival after recurrent malignant rhabdoid tumor. <i>Sarcoma.</i> 2007; <b>2007</b>: 53549. <a target=xrefwindow id=d21564e3418 href="http://www.ncbi.nlm.nih.gov/pubmed/17671630">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3421 href="https://doi.org/10.1155/2007/53549">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3424 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1920592">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d21564e3433 class=n-a></a>Geller JI, Waltz AL: Malignant Rhabdoid Tumor. <i>Medscape.</i> 2018. <a target=xrefwindow id=d21564e3438 href="https://emedicine.medscape.com/article/993084-overview">Reference Source</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d21564e3447 class=n-a></a>Chan V, Marro A, Findlay JM, <i> et al.</i>: A Systematic Review of Atypical Teratoid Rhabdoid Tumor in Adults. <i>Front Oncol.</i> 2018; <b>8</b>: 567. <a target=xrefwindow id=d21564e3458 href="http://www.ncbi.nlm.nih.gov/pubmed/30547013">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3461 href="https://doi.org/10.3389/fonc.2018.00567">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3465 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6279935">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d21564e3474 class=n-a></a>Needs T, Fillman EP: Cancer, Epithelioid Sarcoma. <i>StatPearls.</i> Treasure Island (FL): StatPearls. 2020. <a target=xrefwindow id=d21564e3479 href="http://www.ncbi.nlm.nih.gov/pubmed/30422506">PubMed Abstract </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d21564e3489 class=n-a></a>Jawad MU, Extein J, Min ES, <i> et al.</i>: Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database. <i>Clin Orthop Relat Res.</i> 2009; <b>467</b>(11): 2939–48. <a target=xrefwindow id=d21564e3500 href="http://www.ncbi.nlm.nih.gov/pubmed/19224301">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3503 href="https://doi.org/10.1007/s11999-009-0749-2">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3507 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2758965">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d21564e3516 class=n-a></a>Shetty A, Matrana MR: Renal medullary carcinoma: a case report and brief review of the literature. <i>Ochsner J.</i> 2014; <b>14</b>(2): 270–5. <a target=xrefwindow id=d21564e3524 href="http://www.ncbi.nlm.nih.gov/pubmed/24940141">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3527 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4052598">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d21564e3536 class=n-a></a>Msaouel P: Renal Medullary Carcinoma. National organization for Rare Disorders. 2019. <a target=xrefwindow id=d21564e3538 href="https://rarediseases.org/rare-diseases/renal-medullary-carcinoma">Reference Source</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d21564e3547 class=n-a></a>Du P, Zhu J, Zhang ZD, <i> et al.</i>: Recurrent epithelioid malignant peripheral nerve sheath tumor with neurofibromatosis type 1: A case report and literature review. <i>Oncol Lett.</i> 2019; <b>18</b>(3): 3072–3080. <a target=xrefwindow id=d21564e3558 href="http://www.ncbi.nlm.nih.gov/pubmed/31452784">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3561 href="https://doi.org/10.3892/ol.2019.10676">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3565 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6704279">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d21564e3574 class=n-a></a>Minagawa T, Shioya R, Sato C, <i> et al.</i>: Advanced epithelioid malignant peripheral nerve sheath tumor showing complete response to combined surgery and chemotherapy: a case report. <i>Case Rep Oncol Med.</i> 2011; <b>2011</b>: 705345. <a target=xrefwindow id=d21564e3585 href="http://www.ncbi.nlm.nih.gov/pubmed/22606446">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3588 href="https://doi.org/10.1155/2011/705345">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3592 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3350304">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d21564e3601 class=n-a></a>Salivary Gland Cancer Treatment: Myoepithelial carcinoma. National Cancer Institute Web site. 2019. <a target=xrefwindow id=d21564e3603 href="https://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq#link/_311">Reference Source</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d21564e3613 class=n-a></a>Su YX, Roberts DB, Hanna EY, <i> et al.</i>: Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary Glands. <i>Ann Surg Oncol.</i> 2015; <b>22</b>(11): 3701–7. <a target=xrefwindow id=d21564e3624 href="http://www.ncbi.nlm.nih.gov/pubmed/25636455">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3627 href="https://doi.org/10.1245/s10434-015-4389-3">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d21564e3636 class=n-a></a>Paoluzzi L, Ghesani M: Extraskeletal myxoid chondrosarcoma with massive pulmonary metastases. <i>Clin Sarcoma Res.</i> 2018; <b>8</b>: 20. Published 2018 Dec 5. <a target=xrefwindow id=d21564e3644 href="http://www.ncbi.nlm.nih.gov/pubmed/30534357">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3647 href="https://doi.org/10.1186/s13569-018-0108-8">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3650 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6280406">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d21564e3659 class=n-a></a>Beccaria K, Sainte-Rose C, Zerah M, <i> et al.</i>: Paediatric Chordomas. <i>Orphanet J Rare Dis.</i> 2015; <b>10</b>: 116. <a target=xrefwindow id=d21564e3670 href="http://www.ncbi.nlm.nih.gov/pubmed/26391590">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3673 href="https://doi.org/10.1186/s13023-015-0340-8">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3677 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4578760">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d21564e3686 class=n-a></a>Rare Bone Tumors: Chordoma. National Cancer Institute Web site. 2019; <a target=xrefwindow id=d21564e3688 href="https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-bone-tumors/chordoma">Reference Source</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d21564e3697 class=n-a></a>Smoll NR, Gautschi OP, Radovanovic I, <i> et al.</i>: Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population. <i>Cancer.</i> 2013; <b>119</b>(11): 2029–37. <a target=xrefwindow id=d21564e3708 href="http://www.ncbi.nlm.nih.gov/pubmed/23504991">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3711 href="https://doi.org/10.1002/cncr.28032">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d21564e3720 class=n-a></a>Agaimy A, Haller F, Frohnauer J, <i> et al.</i>: Pancreatic undifferentiated rhabdoid carcinoma: <i>KRAS</i> alterations and SMARCB1 expression status define two subtypes. <i>Mod Pathol.</i> 2015; <b>28</b>(2): 248–60. <a target=xrefwindow id=d21564e3734 href="http://www.ncbi.nlm.nih.gov/pubmed/25103069">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3738 href="https://doi.org/10.1038/modpathol.2014.100">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d21564e3748 class=n-a></a>Agaimy A, Koch M, Lell M, <i> et al.</i>: SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. <i>Am J Surg Pathol.</i> 2014; <b>38</b>(9): 1274–81. <a target=xrefwindow id=d21564e3759 href="http://www.ncbi.nlm.nih.gov/pubmed/24832165">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3762 href="https://doi.org/10.1097/PAS.0000000000000236">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3766 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4141899">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d21564e3775 class=n-a></a>Lee JS, Ko IJ, Jun SY, <i> et al.</i>: Basaloid squamous cell carcinoma in nasal cavity. <i>Clin Exp Otorhinolaryngol.</i> 2009; <b>2</b>(4): 207–10. <a target=xrefwindow id=d21564e3786 href="http://www.ncbi.nlm.nih.gov/pubmed/20072697">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3789 href="https://doi.org/10.3342/ceo.2009.2.4.207">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3793 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2804098">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d21564e3802 class=n-a></a>Öfkeli Ö, Bulut A, Yüksek YN, <i> et al.</i>: Malignant rhabdoid tumour in the stomach. <i>Ulus Cerrahi Derg.</i> 2013; <b>31</b>(1): 55–7. <a target=xrefwindow id=d21564e3813 href="http://www.ncbi.nlm.nih.gov/pubmed/25931936">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3816 href="https://doi.org/10.5152/UCD.2013.46">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3820 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4415548">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d21564e3829 class=n-a></a>Romera Barba E, Sánchez Pérez A, Duque Pérez C, <i> et al.</i>: Malignant rhabdoid tumor of the colon: a case report. <i>Cir Esp.</i> 2014; <b>92</b>(9): 638–40. <a target=xrefwindow id=d21564e3840 href="http://www.ncbi.nlm.nih.gov/pubmed/24856151">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3843 href="https://doi.org/10.1016/j.ciresp.2014.02.004">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d21564e3852 class=n-a></a>Yohay K, Bergner A: Schwannomatosis. UpToDate. 2020. <a target=xrefwindow id=d21564e3854 href="https://www.uptodate.com/contents/schwannomatosis#H13669906">Reference Source</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d21564e3863 class=n-a></a>Morgan J, Raut CP, Duensing A, <i> et al.</i>: Epidemiology, classification, clinical presentation, prognostic features, and diagnostic work-up of gastrointestinal stromal tumors (GIST). <i>UpToDate.</i> 2019.<a target=xrefwindow id=d21564e3871 href="https://www.uptodate.com/contents/epidemiology-classification-clinical-presentation-prognostic-features-and-diagnostic-work-up-of-gastrointestinal-stromal-tumors-gist">Reference Source</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d21564e3881 class=n-a></a>DeMatteo RP, Lewis JJ, Leung D, <i> et al.</i>: Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. <i>Ann Surg.</i> 2000; <b>231</b>(1): 51–58. <a target=xrefwindow id=d21564e3892 href="http://www.ncbi.nlm.nih.gov/pubmed/10636102">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3895 href="https://doi.org/10.1097/00000658-200001000-00008">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3899 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1420965">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d21564e3908 class=n-a></a>Joensuu H, Fletcher C, Dimitrijevic S, <i> et al.</i>: Management of malignant gastrointestinal stromal tumours. <i>Lancet Oncol.</i> 2002; <b>3</b>(11): 655–664. <a target=xrefwindow id=d21564e3919 href="http://www.ncbi.nlm.nih.gov/pubmed/12424067">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3922 href="https://doi.org/10.1016/s1470-2045(02)00899-9">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d21564e3931 class=n-a></a>Howlader N, Noone AM, Krapcho M, <i> et al.</i>: (eds). SEER Cancer Statistics Review, 1975-2016. National Cancer Institute, Bethesda, MD, based on November 2018 SEER data submission, posted to the SEER website, April. 2019. <a target=xrefwindow id=d21564e3936 href="https://seer.cancer.gov/csr/1975_2016/">Reference Source</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d21564e3945 class=n-a></a>Velasco IA, Zhang R, Li T, <i> et al.</i>: Ossifying Fibromyxoid tumor of soft parts in head and neck: case report and literature review. <i>Diagn Pathol.</i> 2018; <b>13</b>(1): 21. <a target=xrefwindow id=d21564e3956 href="http://www.ncbi.nlm.nih.gov/pubmed/29587781">PubMed Abstract </a> | <a target=xrefwindow id=d21564e3959 href="https://doi.org/10.1186/s13000-018-0699-7">Publisher Full Text </a> | <a target=xrefwindow id=d21564e3963 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5870216">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d21564e3972 class=n-a></a>Bakiratharajan D, Rekhi B: Ossifying Fibromyxoid Tumor: An Update. <i>Arch Pathol Lab Med.</i> 2016; <b>140</b>(4): 371–375. <a target=xrefwindow id=d21564e3980 href="https://doi.org/10.5858/arpa.2014-0590-RS">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d21564e3989 class=n-a></a>Pawel BR: SMARCB1-deficient Tumors of Childhood: A Practical Guide. <i>Pediatr Dev Pathol.</i> 2018; <b>21</b>(1): 6–28. <a target=xrefwindow id=d21564e3997 href="http://www.ncbi.nlm.nih.gov/pubmed/29280680">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4000 href="https://doi.org/10.1177/1093526617749671">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d21564e4010 class=n-a></a>Parker NA, Al-Obaidi A, Lalich D, <i> et al.</i>: SMARCB1/INI1-Deficient Extrarenal Rhabdoid Tumor: A Case Report of a Rare and Aggressive Soft Tissue Sarcoma. <i>Cureus.</i> 2020; <b>12</b>(5): e8273. <a target=xrefwindow id=d21564e4021 href="http://www.ncbi.nlm.nih.gov/pubmed/32467817">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4024 href="https://doi.org/10.7759/cureus.8273">Publisher Full Text </a> | <a target=xrefwindow id=d21564e4028 href="http://www.ncbi.nlm.nih.gov/pmc/articles/7250519">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d21564e4037 class=n-a></a>Podduturi V, Campa-Thompson MM, Zhou XJ, <i> et al.</i>: Malignant rhabdoid tumor of the kidney arising in an adult patient. <i>Proc (Bayl Univ Med Cent).</i> 2014; <b>27</b>(3): 239–41. <a target=xrefwindow id=d21564e4048 href="http://www.ncbi.nlm.nih.gov/pubmed/24982576">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4051 href="https://doi.org/10.1080/08998280.2014.11929125">Publisher Full Text </a> | <a target=xrefwindow id=d21564e4055 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4059580">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d21564e4064 class=n-a></a>Peng HQ, Stanek AE, Teichberg S, <i> et al.</i>: Malignant rhabdoid tumor of the kidney in an adult: a case report and review of the literature. <i>Arch Pathol Lab Med.</i> 2003; <b>127</b>(9): e371–e373. <a target=xrefwindow id=d21564e4075 href="http://www.ncbi.nlm.nih.gov/pubmed/12946214">PubMed Abstract </a> | <a target="xrefwindow" id="d21564e4078" href="https://doi.org/10.1043/1543-2165(2003)127<e371:MRTOTK&gt;2.0.CO;2">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d21564e4087 class=n-a></a>Lowe W, Weiss RM, Todd MB, <i> et al.</i>: Malignant rhabdoid tumor of the kidney in an adult. <i>J Urol.</i> 1990; <b>143</b>(1): 110–112. <a target=xrefwindow id=d21564e4098 href="http://www.ncbi.nlm.nih.gov/pubmed/2152948">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4101 href="https://doi.org/10.1016/s0022-5347(17)39882-8">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d21564e4110 class=n-a></a>Clausen HV, Horn T, Anagnostaki L, <i> et al.</i>: Malignant rhabdoid tumour of the kidney in an adult: a case report with immunohistochemical and ultrastructural investigation. <i>Scand J Urol Nephrol Suppl.</i> 1994; <b>157</b>: 123–128. <a target=xrefwindow id=d21564e4121 href="http://www.ncbi.nlm.nih.gov/pubmed/7524139">PubMed Abstract </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d21564e4130 class=n-a></a>Ebbinghaus SW, Herrera G, Marshall ME: Rhabdoid tumor of the kidney in an adult: review of the literature and report of a case responding to interleukin-2. <i>Cancer Biother.</i> 1995; <b>10</b>(3): 237–241. <a target=xrefwindow id=d21564e4138 href="http://www.ncbi.nlm.nih.gov/pubmed/8547962">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4141 href="https://doi.org/10.1089/cbr.1995.10.237">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d21564e4151 class=n-a></a>Caballero JM, Collera P, Marti L, <i> et al.</i>: [Malignant Rhabdoid Tumor of the Kidney in the Adult]. <i>Actas Urol Esp.</i> 1996; <b>20</b>(4): 377–379. <a target=xrefwindow id=d21564e4162 href="http://www.ncbi.nlm.nih.gov/pubmed/8801800">PubMed Abstract </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d21564e4171 class=n-a></a>Zhao G, Na R, Yang Y, <i> et al.</i>: Pure malignant rhabdoid tumor of the left kidney in an adult: A case report and review of the literature. <i>Oncol Lett.</i> 2013; <b>5</b>(5): 1481–1484. <a target=xrefwindow id=d21564e4182 href="http://www.ncbi.nlm.nih.gov/pubmed/23761028">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4185 href="https://doi.org/10.3892/ol.2013.1207">Publisher Full Text </a> | <a target=xrefwindow id=d21564e4189 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3678854">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d21564e4198 class=n-a></a>Modena P, Lualdi E, Facchinetti F, <i> et al.</i>: <i>SMARCB1/INI1</i> tumor suppressor gene is frequently inactivated in epithelioid sarcomas. <i>Cancer Res..</i> 2005; <b>65</b>(10): 4012–9. <a target=xrefwindow id=d21564e4212 href="http://www.ncbi.nlm.nih.gov/pubmed/15899790">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4216 href="https://doi.org/10.1158/0008-5472.CAN-04-3050">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d21564e4225 class=n-a></a>Margol AS, Judkins AR: Pathology and diagnosis of SMARCB1-deficient tumors. <i>Cancer Genet.</i> 2014; <b>207</b>(9): 358–64. <a target=xrefwindow id=d21564e4233 href="http://www.ncbi.nlm.nih.gov/pubmed/25246033">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4236 href="https://doi.org/10.1016/j.cancergen.2014.07.004">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d21564e4245 class=n-a></a>Ng WK, Toe BP, Lau HY: Malignant Rhabdoid Tumor of the Mediastinum: A Case Report and Literature Review. <i>J Clin Imaging Sci.</i> 2019; <b>9</b>: 7. <a target=xrefwindow id=d21564e4253 href="http://www.ncbi.nlm.nih.gov/pubmed/31448158">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4256 href="https://doi.org/10.25259/JCIS-9-7">Publisher Full Text </a> | <a target=xrefwindow id=d21564e4259 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6702892">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d21564e4268 class=n-a></a>Gupta RK, Batra VV, Das MC, <i> et al.</i>: Malignant extra-renal rhabdoid tumor with unusual presentation: A report of two cases. <i>J Cancer Res Ther.</i> 2015; <b>11</b>(4): 963–6. <a target=xrefwindow id=d21564e4279 href="http://www.ncbi.nlm.nih.gov/pubmed/26881557">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4282 href="https://doi.org/10.4103/0973-1482.163668">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d21564e4292 class=n-a></a>Hoot AC, Russo P, Judkins AR, <i> et al.</i>: Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. <i>Am J Surg Pathol..</i> 2004; <b>28</b>(11): 1485–91. <a target=xrefwindow id=d21564e4303 href="http://www.ncbi.nlm.nih.gov/pubmed/15489652">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4306 href="https://doi.org/10.1097/01.pas.0000141390.14548.34">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d21564e4315 class=n-a></a>Chbani L, Guillou L, Terrier P, <i> et al.</i>: Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group. <i>Am J Clin Pathol.</i> 2009; <b>131</b>(2): 222–227. <a target=xrefwindow id=d21564e4326 href="http://www.ncbi.nlm.nih.gov/pubmed/19141382">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4329 href="https://doi.org/10.1309/AJCPU98ABIPVJAIV">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d21564e4338 class=n-a></a>Kohashi K, Tanaka Y, Kishimoto H, <i> et al.</i>: Reclassification of rhabdoid tumor and pediatric undifferentiated/unclassified sarcoma with complete loss of SMARCB1/INI1 protein expression: three subtypes of rhabdoid tumor according to their histological features. <i>Mod Pathol.</i> 2016; <b>29</b>(10): 1232–1242. <a target=xrefwindow id=d21564e4349 href="https://doi.org/10.1038/modpathol.2016.106">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d21564e4358 class=n-a></a>Zhang XW, Deng YJ, Zhou L, <i> et al.</i>: Epithelioid sarcoma of the scalp: a case report and literature review. <i>Int J Clin Exp Pathol.</i> 2019; <b>12</b>(10): 3908–3914. <a target=xrefwindow id=d21564e4369 href="http://www.ncbi.nlm.nih.gov/pubmed/31933781">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4372 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6949740">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d21564e4381 class=n-a></a>Kubota Y, Arakawa Y, Sekiguchi M, <i> et al.</i>: A case of malignant rhabdoid tumor mimicking yolk sac tumor. <i>Pediatr Blood Cancer.</i> 2019; <b>66</b>(8): e27784. <a target=xrefwindow id=d21564e4392 href="http://www.ncbi.nlm.nih.gov/pubmed/31034722">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4395 href="https://doi.org/10.1002/pbc.27784">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d21564e4404 class=n-a></a>Kolin DL, Dong F, Baltay M, <i> et al.</i>: SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma. <i>Mod Pathol.</i> 2018; <b>31</b>(9): 1442–1456. <a target=xrefwindow id=d21564e4415 href="http://www.ncbi.nlm.nih.gov/pubmed/29700418">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4418 href="https://doi.org/10.1038/s41379-018-0049-z">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d21564e4428 class=n-a></a>Kim YS, Kwak HS, Chung GH, <i> et al.</i>: Epithelioid sarcoma arising from the temporal space: A case report. <i>Medicine (Baltimore).</i> 2018; <b>97</b>(38): e12529. <a target=xrefwindow id=d21564e4439 href="http://www.ncbi.nlm.nih.gov/pubmed/30235775">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4442 href="https://doi.org/10.1097/MD.0000000000012529">Publisher Full Text </a> | <a target=xrefwindow id=d21564e4446 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6160058">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d21564e4455 class=n-a></a>Strehl JD, Wachter DL, Fiedler J, <i> et al.</i>: Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. <i>Ann Diagn Pathol.</i> 2015; <b>19</b>(4): 198–202. <a target=xrefwindow id=d21564e4466 href="http://www.ncbi.nlm.nih.gov/pubmed/25920939">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4469 href="https://doi.org/10.1016/j.anndiagpath.2015.04.001">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d21564e4478 class=n-a></a>dos Santos LM, Nogueira L, Matsuo CY, <i> et al.</i>: Proximal-type epithelioid sarcoma -- case report. <i>An Bras Dermatol.</i> 2013; <b>88</b>(3): 444–7. <a target=xrefwindow id=d21564e4489 href="http://www.ncbi.nlm.nih.gov/pubmed/23793215">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4492 href="https://doi.org/10.1590/abd1806-4841.20131922">Publisher Full Text </a> | <a target=xrefwindow id=d21564e4496 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3754382">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d21564e4505 class=n-a></a>Patrizi L, Corrado G, Saltari M, <i> et al.</i>: Vulvar "proximal-type" epithelioid sarcoma: report of a case and review of the literature. <i>Diagn Pathol.</i> 2013; <b>8</b>: 122. <a target=xrefwindow id=d21564e4516 href="http://www.ncbi.nlm.nih.gov/pubmed/23886403">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4519 href="https://doi.org/10.1186/1746-1596-8-122">Publisher Full Text </a> | <a target=xrefwindow id=d21564e4523 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3751136">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d21564e4532 class=n-a></a>Tocco I, Bassetto F, Vindigni V: Primary epithelioid sarcoma of the scalp complicated by humoral hypercalcemia of malignancy. <i>Eplasty.</i> 2012; <b>12</b>: ic18. <a target=xrefwindow id=d21564e4540 href="http://www.ncbi.nlm.nih.gov/pubmed/23359842">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4543 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3552616">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d21564e4552 class=n-a></a>Rizzo D, Fréneaux P, Brisse H, <i> et al.</i>: SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors? <i>Am J Surg Pathol.</i> 2012; <b>36</b>(7): 964–72. <a target=xrefwindow id=d21564e4563 href="http://www.ncbi.nlm.nih.gov/pubmed/22614000">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4566 href="https://doi.org/10.1097/PAS.0b013e31825798f1">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d21564e4576 class=n-a></a>Kuge A, Sato S, Sakurada K, <i> et al.</i>: Atypical teratoid rhabdoid tumor located in the pineal region following prophylactic irradiation for acute lymphoblastic leukemia. <i>Brain Tumor Pathol.</i> 2012; <b>29</b>(3): 177–81. <a target=xrefwindow id=d21564e4587 href="http://www.ncbi.nlm.nih.gov/pubmed/22218708">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4590 href="https://doi.org/10.1007/s10014-011-0075-8">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d21564e4599 class=n-a></a>Hagström J, Mesimäki K, Apajalahti S, <i> et al.</i>: A rare case of oral epithelioid sarcoma of the gingiva. <i>Oral Surg Oral Med Oral Pathol Oral Radiol Endod.</i> 2011; <b>111</b>(4): e25–8. <a target=xrefwindow id=d21564e4610 href="http://www.ncbi.nlm.nih.gov/pubmed/21420628">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4613 href="https://doi.org/10.1016/j.tripleo.2010.12.014">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d21564e4622 class=n-a></a>Narendra H, Ray S, Rao L, <i> et al.</i>: Malignant extrarenal rhabdoid tumor of the vulva in an adult. <i>J Cancer Res Ther.</i> 2010; <b>6</b>(1): 82–5. <a target=xrefwindow id=d21564e4633 href="http://www.ncbi.nlm.nih.gov/pubmed/20479553">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4636 href="https://doi.org/10.4103/0973-1482.63557">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d21564e4645 class=n-a></a>Tholpady A, Lonergan CL, Wick MR: Proximal-type epithelioid sarcoma of the vulva: relationship to malignant extrarenal rhabdoid tumor. <i>Int J Gynecol Pathol.</i> 2010; <b>29</b>(6): 600–4. <a target=xrefwindow id=d21564e4653 href="http://www.ncbi.nlm.nih.gov/pubmed/20881848">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4656 href="https://doi.org/10.1097/PGP.0b013e3181e31f94">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d21564e4665 class=n-a></a>Hornick JL, Dal Cin P, Fletcher CDM: Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. <i>Am J Surg Pathol.</i> 2009; <b>33</b>(4): 542–50. <a target=xrefwindow id=d21564e4673 href="http://www.ncbi.nlm.nih.gov/pubmed/19033866">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4676 href="https://doi.org/10.1097/PAS.0b013e3181882c54">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d21564e4685 class=n-a></a>Kim JH, Choi YS, Lee TS: A case of epithelioid sarcoma arising in the vulva. <i>J Gynecol Oncol.</i> 2008; <b>19</b>(3): 202–204. <a target=xrefwindow id=d21564e4693 href="http://www.ncbi.nlm.nih.gov/pubmed/19471567">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4696 href="https://doi.org/10.3802/jgo.2008.19.3.202">Publisher Full Text </a> | <a target=xrefwindow id=d21564e4699 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2676464">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d21564e4709 class=n-a></a>Rekhi B, Gorad BD, Chinoy RF: Clinicopathological features with outcomes of a series of conventional and proximal-type epithelioid sarcomas, diagnosed over a period of 10 years at a tertiary cancer hospital in India. <i>Virchows Arch.</i> 2008; <b>453</b>(2): 141–153. <a target=xrefwindow id=d21564e4717 href="http://www.ncbi.nlm.nih.gov/pubmed/18607629">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4720 href="https://doi.org/10.1007/s00428-008-0639-0">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d21564e4729 class=n-a></a>Argenta PA, Thomas S, Chura JC: Proximal-type epithelioid sarcoma vs. malignant rhabdoid tumor of the vulva: a case report, review of the literature, and an argument for consolidation. <i>Gynecol Oncol.</i> 2007; <b>107</b>(1): 130–135. <a target=xrefwindow id=d21564e4737 href="http://www.ncbi.nlm.nih.gov/pubmed/17692365">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4740 href="https://doi.org/10.1016/j.ygyno.2007.05.045">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d21564e4749 class=n-a></a>Bourdeaut F, Fréneaux P, Thuille B, <i> et al.</i>: hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. <i>J Pathol.</i> 2007; <b>211</b>(3): 323–330. <a target=xrefwindow id=d21564e4760 href="http://www.ncbi.nlm.nih.gov/pubmed/17152049">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4763 href="https://doi.org/10.1002/path.2103">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d21564e4772 class=n-a></a>Weisskopf M, Münker R, Hermanns-Sachweh B, <i> et al.</i>: Epithelioid sarcoma in the thoracic spine. <i>Eur Spine J.</i> 2006; <b>15 Suppl 5</b>(Suppl 5): 604–609. <a target=xrefwindow id=d21564e4783 href="http://www.ncbi.nlm.nih.gov/pubmed/16474944">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4786 href="https://doi.org/10.1007/s00586-006-0061-8">Publisher Full Text </a> | <a target=xrefwindow id=d21564e4790 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1602205">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d21564e4799 class=n-a></a>Onol FF, Tanidir Y, Kotiloğlu E, <i> et al.</i>: Proximal type epithelioid sarcoma of the scrotum: a source of diagnostic confusion that needs immediate attention. <i>Eur Urol.</i> 2006; <b>49</b>(2): 406–407. <a target=xrefwindow id=d21564e4810 href="http://www.ncbi.nlm.nih.gov/pubmed/16343734">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4813 href="https://doi.org/10.1016/j.eururo.2005.09.020">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d21564e4822 class=n-a></a>Zevallos-Giampietri EA, Barrionuevo C: Proximal-type epithelioid sarcoma: report of two cases in the perineum: differential diagnosis and review of soft tissue tumors with epithelioid and/or rhabdoid features. <i>Appl Immunohistochem Mol Morphol.</i> 2005; <b>13</b>(3): 221–230. <a target=xrefwindow id=d21564e4830 href="http://www.ncbi.nlm.nih.gov/pubmed/16082246">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4833 href="https://doi.org/10.1097/01.pai.0000145131.80060.6c">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d21564e4843 class=n-a></a>Masunaga A, Ikeda K, Suzuki T, <i> et al.</i>: Proximal-type epithelioid sarcoma in a 36-year-old man: closer immunoelectron-microscopic resemblance of the tumor cells to epithelial cells than to mesenchymal cells. <i>Pathol Int.</i> 2004; <b>54</b>(8): 616–622. <a target=xrefwindow id=d21564e4854 href="http://www.ncbi.nlm.nih.gov/pubmed/15260853">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4857 href="https://doi.org/10.1111/j.1440-1827.2004.01671.x">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d21564e4866 class=n-a></a>Chang JH, Dikranian AH, Johnston WH, <i> et al.</i>: Malignant extrarenal rhabdoid tumor of the bladder: 9-year survival after chemotherapy and partial cystectomy. <i>J Urol.</i> 2004; <b>171</b>(2 Pt 1): 820–821. <a target=xrefwindow id=d21564e4877 href="http://www.ncbi.nlm.nih.gov/pubmed/14713833">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4880 href="https://doi.org/10.1097/01.ju.0000107014.40195.cf">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d21564e4889 class=n-a></a>Altundag K, Dikbas O, Oyan B, <i> et al.</i>: Epithelioid sarcoma of vulva: a case report and review of the literature. <i>Med Oncol.</i> 2004; <b>21</b>(4): 367–372. <a target=xrefwindow id=d21564e4900 href="http://www.ncbi.nlm.nih.gov/pubmed/15579921">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4903 href="https://doi.org/10.1385/MO:21:4:367">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d21564e4912 class=n-a></a>Lee MW, Jee KJ, Ro JY, <i> et al.</i>: Proximal-type epithelioid sarcoma: case report and result of comparative genomic hybridization. <i>J Cutan Pathol.</i> 2004; <b>31</b>(1): 67–71. <a target=xrefwindow id=d21564e4923 href="http://www.ncbi.nlm.nih.gov/pubmed/14675288">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4926 href="https://doi.org/10.1046/j.0303-6987.2004.0136.x">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d21564e4935 class=n-a></a>Hanna SL, Kaste S, Jenkins JJ, <i> et al.</i>: Epithelioid sarcoma: clinical, MR imaging and pathologic findings. <i>Skeletal Radiol.</i> 2002; <b>31</b>(7): 400–412. <a target=xrefwindow id=d21564e4946 href="http://www.ncbi.nlm.nih.gov/pubmed/12107573">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4949 href="https://doi.org/10.1007/s00256-002-0509-9">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d21564e4958 class=n-a></a>Etienne-Mastroianni B, Falchero L, Chalabreysse L, <i> et al.</i>: Primary sarcomas of the lung: a clinicopathologic study of 12 cases. <i>Lung Cancer.</i> 2002; <b>38</b>(3): 283–289. <a target=xrefwindow id=d21564e4969 href="http://www.ncbi.nlm.nih.gov/pubmed/12445750">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4972 href="https://doi.org/10.1016/s0169-5002(02)00303-3">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d21564e4982 class=n-a></a>Moore RG, Steinhoff MM, Granai CO, <i> et al.</i>: Vulvar epithelioid sarcoma in pregnancy. <i>Gynecol Oncol.</i> 2002; <b>85</b>(1): 218–222. <a target=xrefwindow id=d21564e4993 href="http://www.ncbi.nlm.nih.gov/pubmed/11925150">PubMed Abstract </a> | <a target=xrefwindow id=d21564e4996 href="https://doi.org/10.1006/gyno.2002.6610">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d21564e5005 class=n-a></a>Haidopoulos D, Elsheikh A, Vlahos G, <i> et al.</i>: Malignant rhabdoid tumor of the clitoris in an elderly patient: report of a case. <i>Eur J Gynaecol Oncol.</i> 2002; <b>23</b>(5): 447–449. <a target=xrefwindow id=d21564e5016 href="http://www.ncbi.nlm.nih.gov/pubmed/12440823">PubMed Abstract </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d21564e5025 class=n-a></a>Tzilinis A, Clarke LE, Affuso C, <i> et al.</i>: Successful treatment of malignant rhabdoid tumor of the vulva in an older patient: a case report and review of the literature. <i>Curr Surg.</i> 2002; <b>59</b>(6): 570–571. <a target=xrefwindow id=d21564e5036 href="http://www.ncbi.nlm.nih.gov/pubmed/16093195">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5039 href="https://doi.org/10.1016/s0149-7944(02)00652-9">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d21564e5048 class=n-a></a>Amrikachi M, Ro JY, Ordonez NG, <i> et al.</i>: Adenocarcinomas of the gastrointestinal tract with prominent rhabdoid features. <i>Ann Diagn Pathol.</i> 2002; <b>6</b>(6): 357–363. <a target=xrefwindow id=d21564e5059 href="http://www.ncbi.nlm.nih.gov/pubmed/12478486">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5062 href="https://doi.org/10.1053/adpa.2002.36657">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d21564e5071 class=n-a></a>Hasegawa T, Matsuno Y, Shimoda T, <i> et al.</i>: Proximal-type epithelioid sarcoma: a clinicopathologic study of 20 cases. <i>Mod Pathol.</i> 2001; <b>14</b>(7): 655–663. <a target=xrefwindow id=d21564e5082 href="http://www.ncbi.nlm.nih.gov/pubmed/11454997">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5085 href="https://doi.org/10.1038/modpathol.3880368">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d21564e5094 class=n-a></a>Kasamatsu T, Hasegawa T, Tsuda H, <i> et al.</i>: Primary epithelioid sarcoma of the vulva. <i>Int J Gynecol Cancer.</i> 2001; <b>11</b>(4): 316–320. <a target=xrefwindow id=d21564e5105 href="http://www.ncbi.nlm.nih.gov/pubmed/11520372">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5108 href="https://doi.org/10.1046/j.1525-1438.2001.011004316.x">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d21564e5118 class=n-a></a>Knapik J, Yachnis AT, Ripley D, <i> et al.</i>: Aggressive uterine sarcoma with rhabdoid features: diagnosis by peritoneal fluid cytology and absence of <i>INI1</i> gene mutation. <i>Hum Pathol.</i> 2001; <b>32</b>(8): 884–886. <a target=xrefwindow id=d21564e5132 href="http://www.ncbi.nlm.nih.gov/pubmed/11521235">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5136 href="https://doi.org/10.1053/hupa.2001.26476">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d21564e5145 class=n-a></a>Biegel JA, Fogelgren B, Wainwright LM, <i> et al.</i>: Germline <i>INI1</i> mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. <i>Genes Chromosomes Cancer.</i> 2000; <b>28</b>(1): 31–37. <a target=xrefwindow id=d21564e5159 href="http://www.ncbi.nlm.nih.gov/pubmed/10738300">PubMed Abstract </a> | <a target="xrefwindow" id="d21564e5163" href="https://doi.org/10.1002/(sici)1098-2264(200005)28:1<31::aid-gcc4&gt;3.0.co;2-y">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d21564e5172 class=n-a></a>Spillane AJ, Thomas JM, Fisher C: Epithelioid sarcoma: the clinicopathological complexities of this rare soft tissue sarcoma. <i>Ann Surg Oncol.</i> 2000; <b>7</b>(3): 218–225. <a target=xrefwindow id=d21564e5180 href="http://www.ncbi.nlm.nih.gov/pubmed/10791853">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5183 href="https://doi.org/10.1007/BF02523657">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d21564e5192 class=n-a></a>Ahmad Z, Stanazai Q, Wright S, <i> et al.</i>: Primary pleural epithelioid sarcoma of the proximal type: a diagnostic and therapeutic challenge. <i>Transl Lung Cancer Res.</i> 2019; <b>8</b>(5): 700–705. <a target=xrefwindow id=d21564e5203 href="http://www.ncbi.nlm.nih.gov/pubmed/31737506">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5206 href="https://doi.org/10.21037/tlcr.2019.09.16">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5210 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6835107">Free Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d21564e5219 class=n-a></a>Bodi I, Giamouriadis A, Sibtain N, <i> et al.</i>: Primary intracerebral INI1-deficient rhabdoid tumor with CD<sub>34</sub> immunopositivity in a young adult. <i>Surg Neurol Int.</i> 2018; <b>9</b>: 45. <a target=xrefwindow id=d21564e5233 href="http://www.ncbi.nlm.nih.gov/pubmed/29541486">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5237 href="https://doi.org/10.4103/sni.sni_334_17">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5240 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5843975">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d21564e5249 class=n-a></a>Gurwale S, Gore C, Kaur S, <i> et al.</i>: Primary epithelioid sarcoma of scalp. <i>Asian J Oncol.</i> 2017; <b>3</b>: 71–73. <a target=xrefwindow id=d21564e5260 href="https://doi.org/10.4103/ASJO.ASJO_113_16">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d21564e5270 class=n-a></a>Saha D, Basu A, Maiti A, <i> et al.</i>: Primary proximal epithelioid sarcoma of the lung successfully treated with pneumonectomy and adjuvant chemotherapy. <i>BMJ Case Rep.</i> 2016; <b>2016</b>: bcr2015213966. <a target=xrefwindow id=d21564e5281 href="http://www.ncbi.nlm.nih.gov/pubmed/27045049">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5284 href="https://doi.org/10.1136/bcr-2015-213966">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5288 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4840621">Free Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d21564e5297 class=n-a></a>Rego JL, Cintra GF, Netto AKJ, <i> et al.</i>: Extremely rare case of vulvar myxoid epithelioid sarcoma. <i>Case Rep Obstet Gynecol.</i> 2015; <b>2015</b>: 971217. <a target=xrefwindow id=d21564e5308 href="http://www.ncbi.nlm.nih.gov/pubmed/25737787">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5311 href="https://doi.org/10.1155/2015/971217">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5315 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4337112">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d21564e5324 class=n-a></a>Wetzel SL, Kerpel S, Reich RF, <i> et al.</i>: Malignant rhabdoid tumor of the floor of mouth: first reported case in the oral cavity of an adult. <i>Head Neck Pathol.</i> 2015; <b>9</b>(2): 269–272. <a target=xrefwindow id=d21564e5335 href="http://www.ncbi.nlm.nih.gov/pubmed/24997629">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5338 href="https://doi.org/10.1007/s12105-014-0555-3">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5342 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4424204">Free Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d21564e5351 class=n-a></a>Agaimy A, Rau TT, Hartmann A, <i> et al.</i>: SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. <i>Am J Surg Pathol.</i> 2014; <b>38</b>(7): 910–920. <a target=xrefwindow id=d21564e5362 href="http://www.ncbi.nlm.nih.gov/pubmed/24503755">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5365 href="https://doi.org/ 10.1097/PAS.0000000000000173">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d21564e5374 class=n-a></a>Madsen GA, Rasmussen TR, Bærentzen S: A case of pleural epithelioid sarcoma of proximal type presenting as malignant pleural mesothelioma. <i>J Thorac Oncol.</i> 2013; <b>8</b>(10): e89–e90. <a target=xrefwindow id=d21564e5382 href="http://www.ncbi.nlm.nih.gov/pubmed/24457248">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5385 href="https://doi.org/10.1097/JTO.0b013e31829e7f16">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d21564e5394 class=n-a></a>Frank R, Sadri N, Bhatti T, <i> et al.</i>: Proximal-type Epithelioid Sarcoma of the Head and Neck (HN): A Study with Immunohistochemical and Molecular Analysis of SMARCB1. <i>J Clin Exp Oncol.</i> 2013; <b>2</b>(2): 1000106. <a target=xrefwindow id=d21564e5405 href="http://www.ncbi.nlm.nih.gov/pubmed/24308011">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5408 href="https://doi.org/10.4172/2324-9110.1000106">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5412 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3846256">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d21564e5422 class=n-a></a>Kim HJ, Kim MH, Kwon J, <i> et al.</i>: Proximal-type epithelioid sarcoma of the vulva with INI1 diagnostic utility. <i>Ann Diagn Pathol.</i> 2012; <b>16</b>(5): 411–415. <a target=xrefwindow id=d21564e5433 href="http://www.ncbi.nlm.nih.gov/pubmed/21724432">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5436 href="https://doi.org/10.1016/j.anndiagpath.2011.04.002">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d21564e5445 class=n-a></a>Mannan AA, Rifaat AA, Kahvic M, <i> et al.</i>: Proximal-type epithelioid sarcoma in the groin presenting as a diagnostic dilemma. <i>Pathol Oncol Res.</i> 2010; <b>16</b>(2): 181–188. <a target=xrefwindow id=d21564e5456 href="http://www.ncbi.nlm.nih.gov/pubmed/19757197">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5459 href="https://doi.org/10.1007/s12253-009-9203-8">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d21564e5468 class=n-a></a>Takei H, Adesina AM, Mehta V, <i> et al.</i>: Atypical teratoid/rhabdoid tumor of the pineal region in an adult. <i>J Neurosurg.</i> 2010; <b>113</b>(2): 374–379. <a target=xrefwindow id=d21564e5479 href="http://www.ncbi.nlm.nih.gov/pubmed/19911885">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5482 href="https://doi.org/10.3171/2009.10.JNS09964">Publisher Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d21564e5491 class=n-a></a>Raoux D, Péoc'h M, Pedeutour F, <i> et al.</i>: Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion. <i>Am J Surg Pathol.</i> 2009; <b>33</b>(6): 954–958. <a target=xrefwindow id=d21564e5502 href="http://www.ncbi.nlm.nih.gov/pubmed/19342946">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5505 href="https://doi.org/10.1097/PAS.0b013e31819b92d5">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d21564e5514 class=n-a></a>Robbens C, Vanwyck R, Wilms G, <i> et al.</i>: An extrarenal rhabdoid tumor of the cervical spine with bony involvement. <i>Skeletal Radiol.</i> 2007; <b>36</b>(4): 341–345. <a target=xrefwindow id=d21564e5525 href="http://www.ncbi.nlm.nih.gov/pubmed/16602014">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5528 href="https://doi.org/10.1007/s00256-006-0104-6">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d21564e5537 class=n-a></a>Sigauke E, Rakheja D, Maddox DL, <i> et al.</i>: Absence of expression of <i>SMARCB1/INI1</i> in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. <i>Mod Pathol.</i> 2006; <b>19</b>(5): 717–725. <a target=xrefwindow id=d21564e5551 href="http://www.ncbi.nlm.nih.gov/pubmed/16528370">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5555 href="https://doi.org/10.1038/modpathol.3800581">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d21564e5565 class=n-a></a>Perry A, Fuller CE, Judkins AR, <i> et al.</i>: INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. <i>Mod Pathol.</i> 2005; <b>18</b>(7): 951–958. <a target=xrefwindow id=d21564e5576 href="http://www.ncbi.nlm.nih.gov/pubmed/15761491">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5579 href="https://doi.org/10.1038/modpathol.3800375">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d21564e5588 class=n-a></a>Edmonson JH, Ryan LM, Blum RH, <i> et al.</i>: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. <i>J Clin Oncol.</i> 1993; <b>11</b>(7): 1269–75. <a target=xrefwindow id=d21564e5599 href="http://www.ncbi.nlm.nih.gov/pubmed/8315424">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5602 href="https://doi.org/10.1200/JCO.1993.11.7.1269">Publisher Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d21564e5611 class=n-a></a>Cesne A, Judson I, Crowther D, <i> et al.</i>: Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group. <i>J Clin Oncol.</i> 2000; <b>18</b>(14): 2676–84. <a target=xrefwindow id=d21564e5622 href="http://www.ncbi.nlm.nih.gov/pubmed/10894866">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5625 href="https://doi.org/10.1200/JCO.2000.18.14.2676">Publisher Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d21564e5634 class=n-a></a>Worden FP, Taylor JM, Biermann JS, <i> et al.</i>: Randomized phase II evaluation of 6 g/m<sup>2</sup> of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m<sup>2</sup> of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma. <i>J Clin Oncol.</i> 2005; <b>23</b>(1): 105–12. <a target=xrefwindow id=d21564e5652 href="http://www.ncbi.nlm.nih.gov/pubmed/15625365">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5655 href="https://doi.org/10.1200/JCO.2005.05.108">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d21564e5664 class=n-a></a>Tap WD, Jones RL, Van Tine BA, <i> et al.</i>: Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial. [published correction appears in Lancet. 2016 Jul 30; 388(10043):464]. <i>Lancet.</i> 2016; <b>388</b>(10043): 488–497. <a target=xrefwindow id=d21564e5675 href="http://www.ncbi.nlm.nih.gov/pubmed/27291997">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5678 href="https://doi.org/10.1016/S0140-6736(16)30587-6">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5682 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5647653">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d21564e5691 class=n-a></a>van Oosterom AT, Judson I, Verweij J, <i> et al.</i>: Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. <i>Lancet.</i> 2001; <b>358</b>(9291): 1421–1423. <a target=xrefwindow id=d21564e5702 href="http://www.ncbi.nlm.nih.gov/pubmed/11705489">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5705 href="https://doi.org/10.1016/s0140-6736(01)06535-7">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d21564e5715 class=n-a></a>Demetri GD, von Mehren M, Blanke CD, <i> et al.</i>: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. <i>N Engl J Med.</i> 2002; <b>347</b>(7): 472–480. <a target=xrefwindow id=d21564e5726 href="http://www.ncbi.nlm.nih.gov/pubmed/12181401">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5729 href="https://doi.org/10.1056/NEJMoa020461">Publisher Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d21564e5738 class=n-a></a>Blanke CD, Rankin C, Demetri GD, <i> et al.</i>: Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. <i>J Clin Oncol.</i> 2008; <b>26</b>(4): 626–632. <a target=xrefwindow id=d21564e5749 href="http://www.ncbi.nlm.nih.gov/pubmed/18235122">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5752 href="https://doi.org/10.1200/JCO.2007.13.4452">Publisher Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d21564e5761 class=n-a></a>Rutkowski P, Van Glabbeke M, Rankin CJ, <i> et al.</i>: Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. <i>J Clin Oncol.</i> 2010; <b>28</b>(10): 1772–1779. <a target=xrefwindow id=d21564e5772 href="http://www.ncbi.nlm.nih.gov/pubmed/20194851">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5775 href="https://doi.org/10.1200/JCO.2009.25.7899">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5779 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3040044">Free Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d21564e5788 class=n-a></a>Stacchiotti S, Pantaleo MA, Negri T, <i> et al.</i>: Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP). <i>Clin Cancer Res.</i> 2016; <b>22</b>(4): 837–846. <a target=xrefwindow id=d21564e5799 href="http://www.ncbi.nlm.nih.gov/pubmed/26261104">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5802 href="https://doi.org/10.1158/1078-0432.CCR-15-1243">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d21564e5811 class=n-a></a>Call JW, Wang Y, Montoya D, <i> et al.</i>: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry. [published correction appears in Clin Sarcoma Res. 2019 May 7;9:7]. <i>Clin Sarcoma Res.</i> 2019; <b>9</b>: 4. <a target=xrefwindow id=d21564e5822 href="http://www.ncbi.nlm.nih.gov/pubmed/30984366">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5825 href="https://doi.org/10.1186/s13569-019-0114-5">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5829 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6446260">Free Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d21564e5838 class=n-a></a>van der Graaf WTA, Blay JY, Chawla SP, <i> et al.</i>: Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. <i>Lancet.</i> 2012; <b>379</b>(9829): 1879–86. <a target=xrefwindow id=d21564e5849 href="http://www.ncbi.nlm.nih.gov/pubmed/22595799">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5852 href="https://doi.org/10.1016/S0140-6736(12)60651-5">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d21564e5862 class=n-a></a>Sleijfer S, Ray-Coquard I, Papai Z, <i> et al.</i>: Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). <i>J Clin Oncol.</i> 2009; <b>27</b>(19): 3126–32. <a target=xrefwindow id=d21564e5873 href="http://www.ncbi.nlm.nih.gov/pubmed/19451427">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5876 href="https://doi.org/10.1200/JCO.2008.21.3223">Publisher Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d21564e5885 class=n-a></a>Ray-Coquard I, Italiano A, Bompas E, <i> et al.</i>: Sorafenib for Patients With Advanced Angiosarcoma: A Phase II Trial From the French Sarcoma Group (GSF/GETO). <i>Oncologist.</i> 2012; <b>17</b>(2): 260–266. <a target=xrefwindow id=d21564e5896 href="http://www.ncbi.nlm.nih.gov/pubmed/22285963">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5899 href="https://doi.org/10.1634/theoncologist.2011-0237">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5903 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3286175">Free Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d21564e5912 class=n-a></a>Kummar S, Allen D, Monks A, <i> et al.</i>: Cediranib for Metastatic Alveolar Soft Part Sarcoma. <i>J Clin Oncol.</i> 2013; <b>31</b>(18): 2296–2302. <a target=xrefwindow id=d21564e5923 href="http://www.ncbi.nlm.nih.gov/pubmed/23630200">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5926 href="https://doi.org/ 10.1200/JCO.2012.47.4288">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5930 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3677840">Free Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d21564e5939 class=n-a></a>Agulnik M, Costa RLB, Milhem M, <i> et al.</i>: A Phase II Study of Tivozanib in Patients With Metastatic and Nonresectable Soft-Tissue Sarcomas. <i>Ann Oncol.</i> 2017; <b>28</b>(1): 121–127. <a target=xrefwindow id=d21564e5950 href="http://www.ncbi.nlm.nih.gov/pubmed/27771610">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5953 href="https://doi.org/10.1093/annonc/mdw444">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5957 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6246191">Free Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d21564e5966 class=n-a></a>Frezza AM, Stacchiotti S, Gronchi A: Systemic Treatment in Advanced Soft Tissue Sarcoma: What Is Standard, What Is New. <i>BMC Med.</i> 2017; <b>15</b>(1): 109. <a target=xrefwindow id=d21564e5974 href="http://www.ncbi.nlm.nih.gov/pubmed/28571564">PubMed Abstract </a> | <a target=xrefwindow id=d21564e5977 href="https://doi.org/10.1186/s12916-017-0872-y">Publisher Full Text </a> | <a target=xrefwindow id=d21564e5980 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5455204">Free Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d21564e5989 class=n-a></a>Binh MB, Sastre-Garau X, Guillou L, <i> et al.</i>: MDM2 and CDK4 Immunostainings Are Useful Adjuncts in Diagnosing Well-Differentiated and Dedifferentiated Liposarcoma Subtypes: A Comparative Analysis of 559 Soft Tissue Neoplasms With Genetic Data. <i>Am J Surg Pathol.</i> 2005; <b>29</b>(10): 1340–1347. <a target=xrefwindow id=d21564e6000 href="http://www.ncbi.nlm.nih.gov/pubmed/16160477">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6003 href="https://doi.org/10.1097/01.pas.0000170343.09562.39">Publisher Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d21564e6013 class=n-a></a>Dickson MA, Tap WD, Keohan ML, <i> et al.</i>: Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced <i>CDK4</i>-amplified well-differentiated or dedifferentiated liposarcoma. <i>J Clin Oncol.</i> 2013; <b>31</b>(16): 2024–8. <a target=xrefwindow id=d21564e6027 href="http://www.ncbi.nlm.nih.gov/pubmed/23569312">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6031 href="https://doi.org/10.1200/JCO.2012.46.5476">Publisher Full Text </a> | <a target=xrefwindow id=d21564e6034 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3661937">Free Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d21564e6043 class=n-a></a>Wilson BG, Wang X, Shen X, <i> et al.</i>: Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. [published correction appears in Cancer Cell. 2011 Jan 18; 19(1): 153] <i>Cancer Cell.</i> 2010; <b>18</b>(4): 316–28. <a target=xrefwindow id=d21564e6054 href="http://www.ncbi.nlm.nih.gov/pubmed/20951942">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6057 href="https://doi.org/10.1016/j.ccr.2010.09.006">Publisher Full Text </a> | <a target=xrefwindow id=d21564e6061 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2957473">Free Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d21564e6070 class=n-a></a>Judson I, Verweij J, Gelderblom H, <i> et al.</i>: Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. <i>Lancet Oncol.</i> 2014; <b>15</b>(4): 415–423. <a target=xrefwindow id=d21564e6081 href="http://www.ncbi.nlm.nih.gov/pubmed/24618336">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6084 href="https://doi.org/10.1016/S1470-2045(14)70063-4">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d21564e6093 class=n-a></a>Ryan CW, Merimsky O, Agulnik M, <i> et al.</i>: PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma. <i>J Clin Oncol.</i> 2016; <b>34</b>(32): 3898–3905. <a target=xrefwindow id=d21564e6104 href="http://www.ncbi.nlm.nih.gov/pubmed/27621408">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6107 href="https://doi.org/10.1200/JCO.2016.67.6684">Publisher Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d21564e6116 class=n-a></a>Tap WD, Papai Z, Van Tine BA, <i> et al.</i>: Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial. <i>Lancet Oncol.</i> 2017; <b>18</b>(8): 1089–1103, [published correction appears in Lancet Oncol. 2018 Feb; 19(2):e78]. <a target=xrefwindow id=d21564e6127 href="http://www.ncbi.nlm.nih.gov/pubmed/28651927">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6130 href="https://doi.org/10.1016/S1470-2045(17)30381-9">Publisher Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d21564e6139 class=n-a></a>Martin-Broto J, Pousa AL, de Las Peñas R, <i> et al.</i>: Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study. <i>J Clin Oncol.</i> 2016; <b>34</b>(19): 2294–2302. <a target=xrefwindow id=d21564e6150 href="http://www.ncbi.nlm.nih.gov/pubmed/27185843">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6153 href="https://doi.org/10.1200/JCO.2015.65.3329">Publisher Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d21564e6163 class=n-a></a>Bui-Nguyen B, Butrynski JE, Penel N, <i> et al.</i>: A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial. <i>Eur J Cancer.</i> 2015; <b>51</b>(10): 1312–1320. <a target=xrefwindow id=d21564e6174 href="http://www.ncbi.nlm.nih.gov/pubmed/25912752">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6177 href="https://doi.org/10.1016/j.ejca.2015.03.023">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d21564e6186 class=n-a></a>Chawla SP, Papai Z, Mukhametshina G, <i> et al.</i>: First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial. <i>JAMA Oncol.</i> 2015; <b>1</b>(9): 1272–1280. <a target=xrefwindow id=d21564e6197 href="http://www.ncbi.nlm.nih.gov/pubmed/26378637">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6200 href="https://doi.org/10.1001/jamaoncol.2015.3101">Publisher Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d21564e6209 class=n-a></a>Gupta S, Gouw L, Wright J, <i> et al.</i>: Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation. <i>Invest New Drugs.</i> 2016; <b>34</b>(2): 243–252. <a target=xrefwindow id=d21564e6220 href="http://www.ncbi.nlm.nih.gov/pubmed/26897615">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6223 href="https://doi.org/10.1007/s10637-016-0333-z">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d21564e6232 class=n-a></a>Seddon B, Strauss SJ, Whelan J, <i> et al.</i>: Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. <i>Lancet Oncol.</i> 2017; <b>18</b>(10): 1397–1410. <a target=xrefwindow id=d21564e6243 href="http://www.ncbi.nlm.nih.gov/pubmed/28882536">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6246 href="https://doi.org/10.1016/S1470-2045(17)30622-8">Publisher Full Text </a> | <a target=xrefwindow id=d21564e6250 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5622179">Free Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d21564e6259 class=n-a></a>Gelderblom H, Blay JY, Seddon BM, <i> et al.</i>: Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study. <i>Eur J Cancer.</i> 2014; <b>50</b>(2): 388–96. <a target=xrefwindow id=d21564e6270 href="http://www.ncbi.nlm.nih.gov/pubmed/24215845">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6273 href="https://doi.org/10.1016/j.ejca.2013.10.002">Publisher Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d21564e6282 class=n-a></a>Penel N, Bui BN, Bay JO, <i> et al.</i>: Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. <i>J Clin Oncol.</i> 2008; <b>26</b>(32): 5269–74. <a target=xrefwindow id=d21564e6293 href="http://www.ncbi.nlm.nih.gov/pubmed/18809609">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6296 href="https://doi.org/10.1200/JCO.2008.17.3146">Publisher Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a name=d21564e6306 class=n-a></a>Agulnik M, Tannir NM, Pressey JG, <i> et al.</i>: A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed/refractory synovial sarcoma. <i>J Clin Oncol.</i> 2016; <b>34</b>(15_suppl): TPS11071–TPS11071. (suppl; abstr TPS11071). <a target=xrefwindow id=d21564e6317 href="https://doi.org/10.1200/JCO.2016.34.15_suppl.TPS11071">Publisher Full Text </a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d21564e6326 class=n-a></a>Wilson BG, Wang X, Shen X, <i> et al.</i>: Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. [published correction appears in Cancer Cell. 2011 Jan 18; 19(1): 153] <i>Cancer Cell.</i> 2010; <b>18</b>(4): 316–28. <a target=xrefwindow id=d21564e6337 href="http://www.ncbi.nlm.nih.gov/pubmed/20951942">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6340 href="https://doi.org/10.1016/j.ccr.2010.09.006">Publisher Full Text </a> | <a target=xrefwindow id=d21564e6344 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2957473">Free Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a name=d21564e6353 class=n-a></a>Msaouel P, Carugo A, Genovese G: Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next? <i>Oncotarget.</i> 2019; <b>10</b>(40): 3979–3981. <a target=xrefwindow id=d21564e6361 href="http://www.ncbi.nlm.nih.gov/pubmed/31258836">PubMed Abstract </a> | <a target=xrefwindow id=d21564e6364 href="https://doi.org/10.18632/oncotarget.26970">Publisher Full Text </a> | <a target=xrefwindow id=d21564e6367 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6592295">Free Full Text </a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d21564e6376 class=n-a></a>Msaouel P, Slack-Tidwell R, Genovese G, <i> et al.</i>: Phase II trial of ixazomib combined with gemcitabine and doxorubicin in patients with SMARCB1-deficient kidney malignancies. <i>J Clin Oncol.</i> 2019; <b>37</b>(7_suppl): (suppl; abstr TPS678–TPS678). <a target=xrefwindow id=d21564e6387 href="https://doi.org/10.1200/JCO.2019.37.7_suppl.TPS678">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div class=f1r-article-desk> <section class="o-box o-box--medium u-bg--2 u-mt--2"> <h4 class="u-mt--0 u-mb--2 t-h3 u-weight--md">Looking for the Open Peer Review Reports?</h4> <p class="u-mt--0 u-mb--0 t-h4">They can now be found at the top of the panel on the right, linked from the box entitled Open Peer Review. Choose the reviewer report you wish to read and click the 'read' link. You can also read all the peer review reports by <a target=_blank href="https://f1000research.com/articles/9-662/v1/pdf?article_uuid=52ca814f-5586-4ab7-b688-8d2e83c0d799">downloading the PDF</a>.</p> </section> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 30 Jun 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-662&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-662&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> University of Kansas School of Medicine, 1010 N Kansas St, Wichita, KS, 67214, USA<br/> <sup>2</sup> Cancer Center of Kansas, 818 N. Emporia #403, Wichita, KS, 67214, USA<br/> <p> <div class=margin-bottom> Nathaniel A. Parker <br/> <span>Roles: </span> Conceptualization, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Ammar Al-Obaidi <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Jeremy M. Deutsch <br/> <span>Roles: </span> Supervision </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/9-662/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 30 Jun 2020, 9:662 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.24808.1">https://doi.org/10.12688/f1000research.24808.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2020 Parker NA <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=27370 data-id=24808 data-downloads="" data-views="" data-scholar="10.12688/f1000research.24808.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/9-662/v1/pdf?article_uuid=52ca814f-5586-4ab7-b688-8d2e83c0d799" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.24808.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Parker NA, Al-Obaidi A and Deutsch JM. SMARCB1/INI1-deficient tumors of adulthood [version 1; peer review: awaiting peer review] <i>F1000Research</i> 2020, <b>9</b>:662 (<a href="https://doi.org/10.12688/f1000research.24808.1" target=_blank>https://doi.org/10.12688/f1000research.24808.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=24808 id=mobile-track-article-signin-24808 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/24808?target=/articles/9-662"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=27370 /> <input name=articleId type=hidden value=24808 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status no-border-and-margin "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <div class=f1r-article-desk-inline><em>AWAITING PEER REVIEW</em></div> <div class="f1r-article-mobile-inline float-right"><em>AWAITING PEER REVIEW</em></div> <span class="circle-icon-small to-right" data-window=about-referee-status title=Help>?</span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 30 Jun 2020</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/9-662&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/9-662&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <div class="p-article__sidebar-highlight u-mb--2"> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="u-ib u-middle"><em>AWAITING PEER REVIEW</em></div> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/9-662&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/9-662/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "SMARCB1\/INI1-deficient tumors of adulthood".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/9-662/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/9-662/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/9-662/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Parker NA et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/9-662/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/9-662",
            templates : {
                twitter : "SMARCB1\/INI1-deficient tumors of adulthood. Parker NA et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/9-662/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: SMARCB1\/INI1-deficient tumors of adulthood", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: SMARCB1\/INI1-deficient tumors of adulthood", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/24808/27370")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("articles", "article", "27370");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "66273": 0,
                           "66272": 0,
                           "66275": 0,
                           "66274": 0,
                           "66789": 0,
                           "67431": 0,
                           "66791": 0,
                           "66790": 0,
                           "67433": 0,
                           "67432": 0,
                           "66792": 0,
                           "68779": 0,
                           "67434": 0,
                           "68781": 0,
                           "68780": 0,
                           "70033": 0,
                           "70034": 0,
                           "70037": 0,
                           "70036": 0,
                           "70038": 0,
                           "66269": 0,
                           "66271": 0,
                           "66270": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "3467e0b9-42c9-4910-be08-e6e0b96d9ee2";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-662.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-662.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/9-662.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/9-662.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/9-662.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>